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ABSTRACT 
 
 
The enantioselective synthesis of (+)-(S)-laudanosine (101) and (–)-(S)-xylopinine (102) were 
achieved successfully in 7 steps from commercially available homoveratylamine (86) in 62% 
and 51% yield, respectively. The key intermediate aminoalkyne 123 was accessed easily by 
coupling aryl iodide 115 and alkyne 121 using a Sonogashira reaction. Dihydroisoquinoline 
124 was obtained by intramolecular hydroamination of the aminoalkyne 123. Employing 
Noyori´s reduction protocol, the absolute configuration at C-1 of the benzylisoquinoline was 
introduced with 93% ee. Finally, methylation of norlaudanosine (146) by a reductive 
amination protocol afforded (+)-(S)-laudanosine (101). Alternatively, formation of the 
berberin-bridge using a Pictet-Spengler reaction afforded (–)-(S)-xylopinine (102). 
 
The strategy was also applied to synthesize benzylisoquinolines with electron-deficient A-
rings. 5-Trifluoromethyl-benzylisoquinoline (174) was successfully synthesized in 8 steps 
from commercially available 4-bromo-trifluorotoluene (162) in 20% yield. Both Sonogashira 
reaction and hydroamination gave the desired products in excellent yields. Moreover, 6,7-
difluoro-benzylisoquinoline (182), was synthesized following a similar route from 
commercially available o-bromo-benzoic acid (175) in 19% yield for the seven steps.  
 
 v
 
KURZZUSAMMENFASSUNG 
 
 
Die enantioselektiven Synthesen von (+)-(S)-Laudanosin (101) und (–)-(S)-Xylopinin (102) 
wurden ausgehend von Homoveratrylamin (86) in 7 Stufen mit Ausbeuten von 62% und 51% 
erfolgreich durchgeführt. Das Aminoalkin 123 wurde leicht aus Aryliodid 144 und Alkin 121 
durch die Sonogashira Kupplungsreaktion hergestellt. Das Dihydroisochinolin 124 wurde 
durch eine intramolekulare Hydroaminierung von Aminoalkin 123 erhalten. Die S-
Konfiguration an C-1 wurde durch eine enantioselektive Reduktion des Imins 124 nach 
Noyori mit 93%-ee erhalten. Eine reduktive Aminierung des erhaltenen Norlaudanosins (146) 
lieferte schlichßlich (+)-(S)-Laudanosin (101). Herstellung der Berberin-Brücke durch eine 
Pictet-Spengler-Reaktion ergab (–)-(S)-Xylopinin (102). 
 
Die Strategie wurde auch zur Synthese von Benzylisochinolinen mit einem elektronenarmen 
A-Ring verwendet. So wurde 5-Trifluormethylbenzylisochinolin (174) über 8 Stufen mit einer 
Ausbeute von 20% aus dem im Handel erhältlichen 4-Bromtrifluortoluol (162) erfolgreich 
synthetisiert. Die Schlüsselschritte, die Sonogashira-Reaktion und die Hydroaminierung, 
verliefen mit sehr guten Ausbeuten. Außerdem wurde 6,7-Difluorbenzylisochinolin (182) über 
7 Stufen mit einer Ausbeute von 19% aus der im Handel erhältlichen o-Brombenzoesäure 
(175) synthetisiert. 
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I  INTRODUCTION 
 
 
1.1. HYDROAMINATION 
 
Nitrogen-containing organic compounds are wide spread in nature and they are therefore 
of great importance for fundamental research and chemical industry. Many amines, 
enamines and imines have well-defined biological functions that are important and even 
essential for life. Many of them are also useful as pharmaceuticals, herbicides, 
fungicides and insecticides, as well as bulk and fine chemicals. With respect to industry, 
several hundred thousand tons of amines are produced worldwide per year.1 The 
classical well-developed methods for their synthesis are the reduction of nitrogen-
containing functionalities in higher oxidation states (e.g., reduction of nitriles, imines, 
azides, nitroso and nitro compounds), nucleophilic substitution of halogen atoms or 
other potential leaving groups at sp3-carbons by ammonia and amines, the Ritter-
reaction and reductive aminations of carbonyl compounds.2 Among these methods, only 
the reductive amination is a highly atom efficient process, that applies versatile and 
inexpensive starting materials and produces a minimal amount of waste. Unfortunately, 
other mentioned, potentially useful processes such as the substitution at sp3-carbons by 
nitrogen nucleophiles often lead to the formation of a mixture of products (primary, 
secondary and tertiary amines, quaternary ammonium salts). 
 
                                                 
1 G. Heilen, H. J. Mercker, D. Frank, R. A. Reck, R. Jäckh, Ullmann´s Encyclopedia of Industrial 
Chemistry, 5th ed., VCH, Weinheim, 1985, vol. A2, p. 1–36. 
2 J. R. Malpass, Comprehensive Organic Chemistry (Eds.: D. Barton, W. D. Ollis), Pergamon Press, 
Oxford, 1979, vol. 2, p. 1−59. 
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The hydroamination of alkenes and alkynes, which constitutes of a formal addition of an 
N-H bond across a carbon-carbon multiple bond (Scheme 1),3 is a transformation of 
fundamental simplicity and would offer the most attractive route to numerous classes of 
organo-nitrogen molecules such as alkylated amines, enamines or imines. This 
fundamentally simple transformation proceeds with 100 % atom efficiency and without 
waste formation. It would offer environmental and economical benefits to chemical 
industry. 
R
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H NR2
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R
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Scheme 1. Hydroamination of alkenes and alkynes. 
 
Thermodynamic considerations indicate that the synthesis of alkylamines by direct 
addition of amines to alkenes is slightly exothermic or approximately thermoneutral.4 
The free energy for the addition of NH3 to H2C=CH2 is estimated to be ∆G° ≈ -15 
kJ/mol. The hydroamination of alkynes is thermodynamically more favorable. The free 
energy for the addition of NH3 to acetylene is estimated (AM1-semiempirical 
calculation) to be ~ 63 kJ/mol more exothermic than the addition to ethylene.5 In 
general, nucleophilic attack of the amine nitrogen bearing the lone electron pair on the 
electron-rich nonactivated alkene leads to electrostatic repulsion. A [2 + 2] cycloaddition 
of N-H to the alkene would be an orbital symmetry-forbidden process and is unfavorable 
because of the high-energy difference between π (C=C) and σ (N-H). At higher 
temperatures, the reaction equilibrium is shifted toward the starting materials because of 
                                                 
3a) T. E.  Müller, M. Beller, Chem. Rev. 1998, 98, 675−703; b) E. Haak, S. Doye, Chem. Unserer Zeit 
1999, 33, 296–303; c) M. Nobis, B. Drießen-Hölscher, Angew. Chem. 2001, 40, 3983–3985; d) F. Pohlki, 
S. Doye, Chem. Soc. Rev. 2003, 32, 104−114; e) M. Beller, A. Tillack, J. Seayed, in: Transition Metals for 
Organic Synthesis (Eds.: M. Beller, C. Bolm), 2nd ed., VCH, Weinheim, 2004, vol. 2, p. 403–414; f) F. 
Alonso, I. P. Beletskaya, M. Yus, Chem. Rev. 2004, 104, 3079–3159. 
4 D. M. Roundhill, Chem. Rev. 1992, 92, 1–27. 
5 T. Straub, A. Haskel, T. G. Neyroud, M. Kapon, M. Botoshansky, M. S. Eisen, Organometallics 2001, 
20, 5017−5035. 
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a highly negative reaction entropy. However, amines will undergo direct nucleophilic 
addition to a carbon-carbon triple bond if the π-system is electron-deficient (e.g., in 
perfluoroalkynes) or activated by neighboring functional groups (e.g., OR, COR, 
COOR, C≡CH).3  
 
The hydroamination can be assisted or catalyzed by alkali metal ions,6 transition metal7 
or lanthanide complexes,8 which allow the processes to be performed under milder 
conditions. Corresponding hydroaminations have been extensively used for the 
generation of small libraries of various classes of biological interesting compounds. 
Hydroamination reactions have also been applied to synthesize natural products. 
 
1.1.1.  HYDROAMINATION IN NATURAL PRODUCTS SYNTHESIS 
The regioselective titanium promoted intramolecular addition of amines to alkynes has 
been applied to the total synthesis of the antifungal agent (+)-preussin (1),9 which 
contains a central pyrrolidine ring. The key step of the synthesis is the cyclization of a 1-
amino-4-alkyne. The 1-amino-4-alkyne 2 was cyclized in the presence of a 
stoichiometric amount of CpTiMe2Cl. Subsequently, the octyl side chain was introduced 
by quenching the intermediate azatitanacyclobutene with octanoyl cyanide to yield 3. 
Two further steps led to (+)-preussin (1) in 33-44% overall yield from aminoalkyne 2. 
 
H
OBn
Ph
H2N N
NC n-C7H15
OBn
Ph
N
OBn
n-C9 H19
CH3
Pha. CpTiMe2Cl
b. C7H12COCN
12 3
 
Scheme 2. The total synthesis of (+)-preussin (1) by Livinghouse et. al. 
                                                 
6 For reviews on base catalyzed hydroamination, see: J. Seayad, A. Tillack, C. G. Hartung, M. Beller,  
Adv. Synth. Catal. 2002, 344, 795−813. 
7 For a review on Group 4 complexes as hydroamination catalysts, see: I. Bytschkov, S. Doye, Eur. J. Org. 
Chem. 2003, 935–946. 
8 For review on organolathanide complexes as hydroamination catalyst, see: S. Hong, T. J. Marks, Acc. 
Chem. Res. 2004, 37, 673–689. 
9 P. L. McGrane, T. Livinghouse, J. Am. Chem. Soc. 1993, 115, 11485–11489. 
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A titanium-catalyzed hydroamination reaction was utilized in the total synthesis of (±)-
monomorine (4).10 The key intermediate, γ-amino alkyne 5, was cyclized with CpTiCl3 
(20 mol-%) in 93% yield and four further steps converted ∆1- pyrroline 6 to (±)-
monomorine (4) in 53% overall yield.  
 
 
O O
NH2
OO
N N
45 6
CpTiCl3 20 mol-%
Et3N
 
Scheme 3. The total synthesis of (±)-monomorine (4) by Livinghouse et. al. 
 
The efficiency and high diastereoselectivity of organolantanide-catalyzed 
hydroaminations/cyclizations of aminoallenes were highlighted by Marks et.al.11 in the 
total synthesis of (+)-xenovenine (7), isolated from Solenopsis xenoveneum, and 
pyrrolidine 197B (8), which was detected in a skin extract of Dendrobates histonicus. 
The constrained geometric organolantanide complex Me2Si(Me4C5)(t-Bu-
N)SmN(TMS)2 (10) efficiently catalyzed the stereoselective tandem bicyclization of 
acyclic compound 9 to the bicyclic pyrrolizidine intermediate 11 under mild conditions. 
Following reduction of the unsaturation using hydrogen in the presence of Pd(OH)2/C, 
(+)-xenovenine (7) was furnished in 78% yield (two steps). In the synthesis of 
pyrrolidine 197B (8), the catalytic ring closure of aminoallene 12 was effected by 
Cp*2SmCH(TMS)2 (13) in pentane solution at 23°C, yielding the expected trans-
pyrrolidine bearing an carbon-carbon double bond 14 with excellent Z-selectivity. 
Hydrogenation led to pyrrolidine 197B (8) in 88% yield (two steps).  
                                                 
10 P. L. McGrane, T. Livinghouse, J. Org. Chem. 1992, 57, 1323–1324. 
11 V. M. Arredondo, S. Tian, F. E. McDonald, T. J. Marks, J. Am. Chem. Soc. 1999, 121, 3633–3639. 
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Scheme 4. The total synthesis of (+)-xenovenine (7) and (+)-pyrrolidine (8) by Marks et. 
al. 
 
Indolizidine alkaloids, isolated from the skin secretion of certain neotropical frogs, 
represent a class of pharmacologically important compounds. Yamamoto et. al.12 has 
applied the Pd(0)/benzoic acid catalyzed intramolecular hydroamination of alkynes to 
synthesize indolizidine 209D (15). This structurally simple example of an indolizidine 
alkaloid acts as a noncompetitive blocker of neuromuscular transmission. The ε-amino 
alkyne 16 was treated with 5 mol-% Pd(PPh3)4 and 10 mol-% benzoic acid and Et3N (2 
equiv) in 1,4-dioxane at 100°C for 12 h to give one diastereoisomer of indolizidine 17 in 
74% yield. Hydrogenation of 17 smoothly gave indolizidine(–)-209D (15) in 85% yield. 
                                                 
12 N. T. Patil, N. K. Pahadi, Y. Yamamoto, Tetrahedron Lett. 2005, 46, 2101–2103. 
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N
H
H
N
H
N
H
5  mol-% Pd(PPh2)4
10 mol-% PhCOOH Pd/C, H2
1516 17
 
Scheme 5. The total synthesis of (–)-indolizidine 209D (15) by Yamamoto et.al. 
 
1.1.2. TITANIUM-CATALYZED HYDROAMINATION 
Catalysis based on titanium complexes in the filed of hydroamination has significant 
advantages compared to processes which are based on toxic (Hg, Tl) or more expensive 
metals (Ru, Rh, Pd, U, Th).3a,3f Inspired by a study on the zirconium-catalyzed 
hydroamination of alkynes by Bergman et. al.13 and the fact that the titanium-catalyzed 
intramolecular hydroamination reaction has already been reported by the Livinghouse 
group,9,10,14 Doye et. al. developed a general method for the catalytic intermolecular 
hydroamination of alkynes.15 
 
As suggested by Bergman, the catalytic-cycle of the Zr-catalyzed hydroamination of 
alkynes,13 involves the catalytically active Zr-imido complex 19, which is formed at a 
temperature above 85°C from the catalyst precursor 18 by reversible and rate 
determining α-elimination of the sterically demanding amine. The imido complex 19 
then undergoes a reversible [2+2]cycloaddition with the employed alkyne 21 yielding an 
azazirconacyclobutene 20. Rapid protonation of the Zr-C bond by excess amine gives 
the bisamide 22, which finally undergoes α-elimination of the enamine product 23 
generating the catalytically active species 19 (Scheme 6). 
                                                 
13 P. J. Walsh, A. M. Baranger, R. G. Bergman, J. Am. Chem. Soc. 1992, 114, 1708–1719; b) A. M. 
Baranger, P. J. Walsh, R. G. Bergman, J. Am. Chem. Soc. 1993, 115, 2753–2763. 
14 P. L. McGrane, M. Jensen, T. Livinghouse, J. Am. Chem. Soc. 1992, 114, 5459–4560. 
15 For an account, see: S. Doye, Synlett 2004, 1653–1672. 
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Cp2Zr NR
[Cp2Zr=NR]
NR
Cp2
Zr
RHN
RNH2
NHR
Cp2Zr(NHR)2
18
RNH2
21
20
22
23
19
R = 2,6-Me2C6H3  
Scheme 6.  Mechanism of the Zr-catalyzed hydroamination suggested by Bergman. 
 
Doye´s strategie to improve the Bergman catalytic cycle, which was limited to the use of 
2,6-dimethylaniline, was to make sure that the equilibrium between complex 19 and the  
corresponding bisamide 18 is on the side of the imido complex 19 and to avoid the 
dimerization of the imido complex 19 to form a catalytically inactive dimer, if the amine 
is smaller than 2,6-dimethylamine. The first improvement should undoubtly result in 
increased reaction rates and should also avoid the inhibition of the catalytic reaction by 
the amine starting material. The second improvement should secure the possible use of 
the catalytic cycle for reactions of any amine.  
 
Doye´s group reported that Cp2TiMe2 (24) is a very efficient catalyst for the 
intermolecular hydroamination on alkynes.16 By using Cp2TiMe2 (24) as catalyst, 
primary aryl amines, t-alkyl and sec-alkyl amines can be reacted with alkynes in high 
yields. The reactions occurred with high regioselectivity for unsymmetricly substituted 
                                                 
16 A) E. Haak, I. Bytschkov, S. Doye, Angew. Chem. 1999, 111, 3584–3586; b) E. Haak, H. Siebeneicher, 
S. Doye, Org. Lett. 2000, 2, 1935–1937. 
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alkynes. Cp2TiMe2 also catalyzed intramolecular hydroaminations/ cyclyzations of 
amino alkynes.17 Unfortunately, n-alkyl- and benzyl amines are poor substrates for the 
Cp2TiMe2 catalyzed intermolecular hydroamination. It has also been observed that the 
hydroamination step was responsible for a partial racemization if enantiometrically pure 
amines were employed.18 
L1L2Ti NR
Ph CH3
[L1L2Ti=NR]
CH3Ph
CH3
NR
Ph
L1L2
Ti
RHN
RNH2
Ph
NHR
CH3
Cp2TiMe2 L1L2Ti(NHR)2
R
N
1L2LTi
N
R
TiL1L2
Ph
NR
CH3
+ RNH2
-RNH2
RNH2
1/2
24
25
27
28
2930
31
32
26
R: 4-MeC6H4
L1L2: Cp, NHR
 
Scheme 7. Mechanism of Cp2TiMe2 catalyzed hydroamination. 
 
According to a kinetic study,19 the catalytic cycle includes a reversible dimerization of 
the catalytically active imido complex 25 and a reversible addition of the amine to 25 
yielding the bisamide 32. The equilibrium between the catalytically active imido 
complex 25 and the bisamide 32 is far on the side of 32 and not on the side of the imido 
complex 25 (see scheme 7). DFT calculations by Bergmann and Straub20 strongly 
                                                 
17 I. Bytschkov, S. Doye, Tetrahedron Lett. 2002, 43, 3715–3718. 
18 F. Pohlki, I. Bytschkov, H. Siebeneicher, A. Heutling, W. A. König, S. Doye, Eur. J. Org. Chem. 2004, 
1967–1972. 
19 F. Pohlki, S. Doye,  Angew. Chem. 2001, 113, 2361–2364. 
20 B. F. Straub, R. G. Bergman,  Angew. Chem. 2001, 113, 4768–4771. 
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support this interpretation of the kinetic study. It was found that using Cp2TiMe2 as catalyst 
precursor obviously did not avoid the dimerization of the catalytically active imido complex. 
 
 
To reach the targets, Doye applied then a bigger ligand than cyclopentadienyl (Cp). 
Using Cp*2TiMe2 as catalyst, hydroamination reactions between n-alkyl-, or 
benzylamines and alkynes took place to give the desired products, unfortunately, with 
low regioselectivities, when unsymmetrically substituted 1-aryl-2-alkylalkynes were 
employed.21 
 
After a screening of hydroamination catalysts based on Ti-complexes,22 Doye´s group 
found that Ind2TiMe2 (33) catalyzed the intermolecular hydroamination of internal and 
terminal alkynes with primary-aryl-, t-alkyl-, sec-alkyl-, n-alkylamines, and even 
benzylamines with modest to excellent regioselectivity. Using Ind2TiMe2 (33) as a 
catalyst no dimerization of the catalytically active imido complex was observed. 
Ind2TiMe2 (33) could be claimed as the first general catalyst with improved activity that 
can be used efficiently for all substrate combinations in intermolecular hydroamination 
reaction.23 
Ti
CH3
CH3
Ti
CH3
CH3
24 33 34
N Ti
N
N CH3
N(CH3)2
N(CH3)2
 
Figure 1. Titanium complexes which have already been used as catalysts of 
hydroamination reaction. 
 
                                                 
21 A. Heutling, S. Doye,  J. Org. Chem. 2002, 67, 1961–1964. 
22 F. Pohlki, A. Heutling, I. Bytschkov, T. Hotopp, S. Doye, Synlett 2002, 799–801. 
23 A. Heutling, F. Pohlki, S. Doye, Chem. Eur. J.  2004, 10, 3059–3071. 
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Titanium-catalyzed hydroaminations of alkynes are not only limited to metallocene or 
Cp-based systems. Odom et. al.24 reported that even the simple complex Ti(NMe2)4 
could be applied as precatalyst for the hydroamination of alkynes. The new Ti-pyrrolyl 
complex Ti(NMe2)2(dmpa) (34) which can be generated from Ti(NMe2)4 and di-
(pirrolyl-α-methyl)methylamine (H2-dmpa) catalyzed also hydroamination reactions of 
alkynes. This catalyst, having a bulky ancillary ligand, was more efficient and selective 
than Ti(NMe2)4 in hydroaminations with aliphatic and aromatic amines. Using this 
catalyst, new methods for the synthesis of imines, hydrazones, α,β-unsaturated imines, 
pyridines, indoles and pyrroles have been developed.25 
 
1.1.3. TITANIUM-CATALYZED HYDROAMINATIONS USED FOR SYNTHESIS OF 
BIOLOGICALLY INTERESTING COMPOUNDS. 
Titanium catalyzed hydroaminations of the alkynes and a subsequent Lewis-acid 
catalyzed nucleophilic addition of diethyl- or dimethyl-phosphite have been applied to a 
one-pot procedure for the synthesis of α-amino phosphonic acid derivatives (35 and 
36).26 Using this method, both acyclic and cyclic α-amino phophonates could be easy 
synthesized. 
R1 R2
R1
R2
NR3
R1
R2
R3HN P(O)(OR4)2
R5
H2N N
R5
N
H
R5
(R4O)2(O)P
n
n n
+
R3 NH2
3.0-5.0 mol-% Cp2TiMe2
3.0-5.0 mol-% Cp2TiMe2
HPO(OR4)2
5 mol-% Me2AlCl
HPO(OR4)2
5 mol-% Me2AlCl
R1, R2, R3: aryl, alkyl
R4: -CH3, -C2H5
R5: aryl
n: 1,2
35
36
 
Scheme 8. Synthesis of α-amino phosphonate derivatives. 
 
                                                 
24 a) Y. Shi, J. T. Ciszewski, A. L. Odom, Organometallics 2001, 20, 3967–3969; b) Y. Shi, J. T. 
Ciszewski, A. L. Odom, Organometallics 2002, 21, 5148–5148. 
25 Recent resume of Odom´s works, see: A. L. Odom, Dalton Trans. 2005, 225–233. 
26 E. Haak, I. Bytschkov, S. Doye, Eur. J. Org. Chem. 2002, 457–463. 
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A highly flexible procedure to synthesize 2-arylethylamine derivatives (37) has also 
been developed involving a Ti-catalyzed hydroamination.27 The reaction starts with a 
Pd-catalyzed coupling between an aryl halide and a terminal alkyne (Sonogashira 
reaction). A subsequent regioselective Ti-catalyzed hydroamination of the alkynes, 
followed by a final reduction of the obtained imines gave 2-arylethylamines in good to 
excellent yields. From a mathematical point of view, 20 aryl halide, 20 terminal alkynes 
and 20 primary amines could be converted into 8000 different 2-arylethylamine 
derivatives by the synthetic approach. 
R2
R1
+
X R1
R2
R1
R2
HN
R3Sonogashira coupling
1. Ti-cat.
2. Reduction
37
H2N R3
 
Scheme 9. Synthesis of 2-arylethylamine. 
R2
Cl
R1
NH2R3 Cl
R2
NR3
R1
Cl
R2
NHR3
R1
N
R3
R2
5.0 mol-% Cp2TiMe2
5.0 mol-% Pd2(dba)3
10.0 mol-% L
KOtBu, 1,4.dioxane
R3: t-Bu-, p-Tol, 4-MeOC6H4, rac-CH(Ph)Me
Cl-
N N
L:
baseR1
38
39
40
41
 
Scheme 10. The one pot procedure of synthesis of indole derivatives by Doye. 
 
                                                 
27 a) H. Siebeneicher, S. Doye, Eur. J. Org. Chem. 2002, 1213–1220; b) A. Heutling, R. Severin, S. Doye, 
Synthesis, 2005, 1200–1204. 
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Doye et. al. demonstrated a combination of a Titanium-catalyzed hydroamination and a 
subsequent Palladium-catalyzed Buchwald-Hartwig reaction in one-pot to give 1,2-; 
1,2,5- and 1,2,6-substituted indoles (e.g.: 42, 43, 44 respectively) in good yields. This 
procedure offers a great deal of synthetic flexibility, since the employed starting 
materials are easily accessible from 1-chloro-2-iodobenzenes and terminal alkynes by 
Sonogashira coupling reactions.28 
 
N
OCH3
N
BnO
OCH3
H3CO
NN
Ph Ph
N
F3C
42 43 44 45
 
Figure 2. Several indoles synthesized applying Doye´s procedure. 
 
Ackermann et.al. has also achieved a one-pot indole synthesis consisting of a highly 
regioselective TiCl4-catalyzed hydroamination and a 5-endo Heck cyclization.29 The 
reaction between an internal alkyne and 2-chloroaniline (47) in the presence of TiCl4 and 
tBuNH2 at 105°C leads to an enamine 49. After the addition of Pd(OAc)2, an N-
heterocyclic carbene (NHC) ligand and tBuOK, the 2,3-disubstituted indoles 46 were 
obtained with complementary regiosectivity of Larock´s annulations indole products.30 
 
Cl
NH2
Ar
R
N
H
R
ArCl
N
Ar
R
H
10 mol-% TiCl4
tBuNH2, PhMe
5 mol-% Pd(dba)2
5 mol-% NHC·HCl
tBuOK
47 4948 46
Scheme 11. The one pot procedure of synthesis of indoline derivatives by Ackermann. 
                                                 
28 H. Siebeneicher, I. Bytschkov, S. Doye, Angew. Chem. 2003, 115, 3151–3153. 
29 L. Ackermann, L. T. Kaspar, C. J. Gschrei, Chem. Comm. 2004, 2824–2825. 
30 R. C. Larock, E. K. Yum, M. D. Refvik, J. Org. Chem. 1998, 63, 7652-7662. 
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N
H
Ph
Ph
N
H
C6H13
N
H
C6H13
N
H
C4H9
CH3 OCH3
CF3
50 51 52 53
Figure 3. Several 2,3-substituted indoles synthesized applying Ackermann procedure. 
 
1.2. BENZYLISOQUINOLINE ALKALOIDS 
Benzylisoquinoline alkaloids are a large and diverse group of secondary metabolites 
found mainly in five related plant families, including Papaveraceae and Ranunculaceae, 
with more than 2500 defined structures. Several benzylisoquinoline alkaloids play 
important ecophysiological roles in the interaction between plants and other organisms, 
especially pathogens and herbivores. The pharmacological activity of benzylisoquinoline 
alkaloids renders many of them useful as pharmaceuticals and is often a clue to their 
biological role in the plant.  
 
1.2.1. USES OF BENZYLISOQUINOLINE ALKALOIDS 
The benzylisoquinoline class of alkaloids contains such varied physiologically active 
members of opium alkaloids as the narcotic analgesic morphine (55), the antitussive and 
narcotic codeine (56), the antitussive noscapine (57), and the vasodilator papaverine 
(58).31 The antibacterial berberine (59) is used in treatment of eye and intestinal 
infection. The form of an extract of Carydalis cava contains the sedative corydaline 
(60). The form of an extract from Sanguinaria canadenses that is used in a toothpaste 
and oral rinse additive contains the antibacterial sanguinarine (61). Tubocurarine (62), a 
non-depolarizing muscle relaxant, is used as an adjuvant to anesthesia to produce 
temporary paralysis from Chondodendron tomentosum. From the collection of 
pharmaceuticals, only papaverine (58) is synthetically produced for industrial uses. The 
remaining alkaloids presented (see scheme 12) are either purified from plants or are used 
                                                 
31 For review of opium alkaloids, see: P. L. Schiff Jr., Am. J. Pharm. Educ. 2002, 66, 186–194. 
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in the form of a crude extract. All of these industrially useful natural products are 
biosynthetically intermediated by (S)-reticuline (54).32 
 
 
NCH3
OH
OCH3
H3CO
HO
HO
HO
NCH3
O
O
O
NCH3
HO
H3CO
O
NCH3
Morphine (55) Codeine (56)
OMe
O
H3CO OCH3
O
H
Noscapine (57)
N
OCH3
OCH3
H3CO
H3CO
Reticuline (54)Papaverine (58)
N
OCH3
OCH3
O
O
Berberine (59)
N
OCH3
OCH3
H3CO
H3CO H
H3C
Corydaline (60)
N
O
O
O
O
CH3
Sanguinarine (61)
Papaver somniferum Papaver somniferum Papaver somniferum
Papaver somniferum Berberis vulgaris
Corydalis cava Sanguinaria canadensis
NCH3
O
H3CO
O
N
OCH3
OH
OH
H3C
H3C
Tubocurarine (62)
Chondodendron tomentosum  
Scheme 12. Pharmaceutically useful alkaloid derivatives formed from the 
benzylisoquinoline alkaloid (S)-reticuline (54). 
 
                                                 
32 For review, see: T. M. Kutchan, in: The Alkaloids: Chemistry and Biology (Eds.: G. A. Cordell), 
Academic Press, San Diego, 1998, vol. 50, 258–316. 
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1.2.2. BIOSYNTHESIS OF BENZYLISOQUINOLINE ALKALOIDS 
 
 
HO
COOH
NH2
HO
NH2 HO
COOH
O
HO
COOH
NH2
HO
HO
NH2
HO
HO
O
H
HO
NH
HO
OH
HO
NCH3
H3CO
OH
HO
NH
H3CO
OH
HO
NCH3
H3CO
OCH3
OH
HO
NCH3
H3CO
OH
OH
Tyrosine
decarboxylase Phenoloxydase
Trans-aminase
CO2
Phenol
oxydase Dopa
decarboxylase
Decarboxylase
CO2
CO2
(S)-Norcoclaurine
synthase
Norcoclaurine
6-O-Methyl
transferase
Coclaurine
N-Methyl
transferase
(S)-N-methyl
coclaurine
3'-hydroxylase 3'-Hydroxy-N-
methylcoclaurine
4'-O-Methyl
transferase
54
L-Tyrosine (63)
Dopamine (66) 4-Hydroxyphenyl- 
acetaldehyde (68)
(S)-Norcoclaurine (69)
64 65 67
70
71
72  
Scheme 13. Biosynthetic pathway leading to (S)-reticuline (54). 
 
All benzylisoquinoline alkaloids share a common biosynthetic origin beginning with a 
lattice of decarboxylations, o-hydroxylations, and deaminations that convert L-tyrosine 
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(63) into both dopamine (66) and 4-hydroxyphenyl acetaldehyde (68).33 The first 
committed step in benzylisoquinoline alkaloid biosynthesis is catalyzed by (S)-
norcoclaurine synthase, which condenses dopamine (66) and 4-
hydroxyphenylacetaldehyde (68) to form the trihydroxylated alkaloid (S)-norcoclaurine 
(69) (see scheme 13).34 Sequential 6-O-methylation of (S)-norcoclaurine (69), followed 
by N-methylation, a P450-dependent 3’ hydroxylation, and subsequent 4’-O-methylation 
lead to the formation of (S)-reticuline (54), an important branch-point intermediate in 
benzylisoquinoline alkaloid biosynthesis.35 Major strides have been made in the 
elucidation of the enzymatic synthesis of tetrahydrobenzylisoquinoline alkaloids due in 
large part to the use of plant cell suspension cultures that have been optimized for the 
production of selected alkaloids. 
 
1.2.3. SYNTHESIS OF ISOQUINOLINE DERIVATIVES. 
The frequent occurrence of the isoquinoline nucleus in alkaloids has led to considerable 
interest in the synthesis of isoquinoline derivatives. The traditional and classical 
methods (Bischler-Napieralski-, Pictet-Spengler- and Pommeranz-Fritsch cyclization) 
have been modified to asymmetric synthesis.36  
 
BISCHLER-NAPIERALSKI CYCLIZATION/REDUCTION 
 
NH
R1
R2
O
N
R1
NH
R1
R2R2
P2O5 or POCl3 [H]
73 74 75  
Scheme 14. Bischler-Napieralski Cyclization/Reduction. 
 
                                                 
33 a. M. Rueffer, M. H. Zenk,  Z. Naturforsch. 1987, 42, 319–332; b. N. Samanani, P.J. Facchini, J. Biol. 
Chem. 2002, 277, 33878-33883.. 
34 a) R. Stadler, T. M. Kutchan, S. Löffler, N. Nagakura, B. K. Cassels, M. H. Zenk, Tetrahedron Lett. 
1987, 28, 1251–1254; b) R. Stadler, T. M. Kutchan, M. H. Zenk, Phytochemistry 1989, 28, 1083–1086. 
35 For recent review: P. J. Facchini, Annu. Rev. Plant Physiol. Plant Mol. Biol. 2001, 52, 29–66. 
36 For reviews, see: M. Chrzanowska, M. D. Rozwadowska, Chem. Rev. 2004, 104, 3341–3370. 
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The Bischler-Napieralski reaction involves the cyclization of phenylethyl amides (73) in 
the presence of dehydrating agents such as P2O5 or POCl3 to afford 3,4-
dihydroisoquinoline products (74).37 Since the yields are very poor under the conditions 
original described for the reaction, modifications using lower temperature and milder 
condensing agents has improved the reaction.38 Reduction of the imines 74 yields 
tetrahydroisoquinoline derivatives (75). The stereochemical outcome of the sequential 
Bischer-Napieralski cyclization/reduction can be determined in the reduction process 
either by diastereoselective or enantioselective methods. 
 
N
R
H3CO
H3CO N
OBn
N
R
H3CO
H3CO N
OBn
N
H3CO
H3CO CH3
NH
CH3
H3CO
H3CO
OCH3
OCH3
NaBH4
MeOH, -50 °C
1. BH3·THF
2. HCHO
    HCOOH
BH3·THF
R: -CH3 (78a)
R: 3,4-(OMe)2C6H3 (78b)
77
7679
R: -CH3
R: 3,4-(OMe)2C6H3
 
Scheme 15. The synthesis of (+)-(R)-salsolidine (76) and (–)-(R)-cryptostyline II (77) by 
Kibayashi et.al. 
 
Numerous modifications of this reaction sequence have been reported.35 In one of them, 
Kibayashi et. al.39 used dihydroisoquinoline salts 78a and 78b containing a chiral 
hydrazonium functionality in the synthesis of (+)-(R)-salsolidine (76) and (–)-(R)- 
cryptostyline II (77). Reduction of 78a and 78b employing sodium borohydride as well 
                                                 
37 A. Bischler, B. Napieralski, Ber. 1893, 26, 1903–1908.  
38 W. M. Whaley, T. R. Govindachari, in: Organic Reaction (ed.: R. Adams), John Wiley & Sons, 
London, 1951, vol. VI, 74–150.  
39 H. Suzuki, S. Aoyagi, C. Kibayashi, Tetrahedron Lett. 1995, 36, 6709–6712. 
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as other metal hydride reagents resulted in the formation of tetrahydroisoquinolines with 
excellent diastereoselectivities (90-96% de). Reductive N-N bond cleavage converted 79 
into the alkaloids (+)-(R)-76 and (–)-(R)-77, respectively. The efficiency of the 
asymmetric induction was postulated to arise from the pyramidal stability of the 
pyrrolidine sp3-hybridized nitrogen atom and hydride-ion approach to the imine double 
bond from the sterically less shielded side.40  
 
Enantioselective synthesis of isoquinoline alkaloids according to a Bischler-Napieralski 
cyclization/reduction approach is based on an enantioselective reduction of prochiral 
3,4-dihydroisoquinolines. For this purpose chiral hydride reducing agents or chiral 
hydrogenation-catalysts are used to introduce the desired chiral centers. Excellent results 
have been described by Buchwald and Willoughby,41 in which chiral titanocene catalysts 
80 (see figure 4) were introduced to control the stereoselectivity of the hydrogenation of 
cyclic imines with excellent levels of enantiomeric excess (95-99% ee).  
O
O
X + X :
N
H2
Ru
NPh
Ph
SO2
Cl
Tol
N
H2
Ru
N Ph
Ph
SO2
Cl
Tol
(S,S) 81a (R,R) 81b
80
X XTi
 
Figure 4. Some enantioselective catalysts for hydrogenation of imines. 
 
The prime procedure of asymmetric imine reduction was reported by Noyori et.al.42 
under the conditions of a transfer hydrogenation with an azeotrope mixture of formic 
                                                 
40 H. Suzuki, S. Aoyagi, C. Kibayashi, J. Org. Chem. 1995, 60, 6114-6122. 
41 a) C. A. Willoughby, S. L. Buchwald,  J. Am. Chem. Soc. 1992, 114, 7562–7564; b) C. A. Willoughby, 
S. L. Buchwald,  J. Am. Chem. Soc. 1994, 116, 8952–8962. 
42 a) N. Uematsu, A. Fujii, S. Hashiguchi, T. Ikariya, R. Noyori, J. Am. Chem. Soc. 1996, 118, 4916–1417; 
b) for reviews using the Ru-catalyst, see: R. Noyori, S. Hashiguchi, Acc. Chem. Res. 1997, 30, 97–102. 
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acid/triethylamine in the presence of the chiral diamine-Ru(II)-η6arene complexes 81a 
and 81b. Currently, this procedure has become the preferred method for enantioselective 
reductions of cyclic imines. As described by Noyori’s group, several isoquinoline 
derivatives have been prepared in high yields with high ee values, starting from cyclic 
imines 82 (R: CH3-, C6H5-, 3,4-(OMe)2C6H3(CH2)2-, and 3,4-(OMe)2C6H3). It has been 
shown that the absolute configuration of the catalyst determined that of the resulting 
amine. Accordingly, products with (1R) configuration were obtained when the catalyst 
(S,S)-81a was used, whereas the (1S) isomers were obtained when the catalyst (R,R)-81b 
was applied, as illustrated in scheme 16. 
 
N
R
H3CO
H3CO
NH
R
H3CO
H3CO
NH
R
H3CO
H3CO
(S,S)-81a
HCOOH/
Et3N
(R,R)-81b
HCOOH/
Et3N
R: -CH3                 (83a)   95% ee
     -C6H5               (83b)   84% ee
     -C6H3(OCH3)2 (83c)   84% ee
82
R: -(CH2)C6H3)(OCH3)2  (83d)  84% ee
 
 
Scheme 16. The enantioselective imine reduction of dihydroisoquinolines following 
Noyori´s procedure. 
 
PICTET-SPENGLER REACTION 
The Pictet-Spengler reaction involves the condensation of a β-arylehtylamine 85 with a 
carbonyl compound to give the corresponding tetrahydroisoquinoline 84. These 
reactions are generally catalyzed by protic or Lewis acids, although numerous thermally-
mediated examples are found in the literature. Aromatic compounds containing electron-
donating substituents are the most reactive substrates for this reaction 
N
R1
RO
RO R2
HN
RO
RO R2 R
1
O
H
+
8485
acid
  or
heat
 
Scheme 17. Pictet-Spengler isoquinoline synthesis. 
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Stereoselective Pictet-Spengler reactions have been developed in various modifications. 
Among them, Chan et.al.43 used a chiral synthetic equivalent of acetaldehyde 87 to 
obtain a single tetrahydroisoquinoline diastereomer 90 as a result of a one-pot Michael 
addition cyclization process. N-Methylation and subsequent desulphurization with 
Raney nickel gave enantiomerically pure (+)-(R)-carnegine (91) in good yield (see 
scheme 18). 
 
NH2
H3CO
H3CO
S
O
O2N
NH
H3CO
H3CO
NH
H3CO
H3CO
S S
O O
O2N O2N
NH
H3CO
H3CO
S
O
O2N
N
H3CO
H3CO
CH3
CH3
F3CCOOH
1. HCHO
    NaBH3CN
 2. Raney Ni
86
87
88 89
90
91
- H+
H+
 
Scheme 18. The synthesis of (+)-(R)-carnegine (91) via Pictet-Spengler cyclization by 
Chan et. al. 
 
POMERANZ-FRITSCH REACTION 
The Pomeranz-Fritsch reaction involves the preparation of isoquinolines via the acid 
mediated cyclization of an appropriate iminoacetal intermediate 92.44 A modification by 
                                                 
43 a) W. Chan, A. W. M. Lee, L. Jiang, Tetrahedron Lett. 1995, 36, 715–718; b) A. W. M. Lee, W. H. 
Chan, Y. Tao, Y. K. Lee, J. Chem. Soc., Perkin Trans. 1 1994, 477–481. 
44 a) C. Pommeranz, Monatsh. 1893, 14, 116; b) P. Fritsch, Ber. 1893, 18, 419–422; c) W. J. Gesler, in: 
Organic Reactions (ed.: R. Adams), John Wiley and Sons, London, 1951, vol. VI, 191–206. 
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Bobbit is the most widely used variation of the Pomeranz-Fritsch reaction. 45 This 
modification involves cyclization of benzylaminoacetal 93, usually prepared from 
classical Pomeranz-Fritsch imine 92, to yield 4-hydroxy derivatives 94. 
Tetrahydroisoquinoline 96 can be otained after removing hydroxyl group. With this 
method, the C-1 stereocenter can be prepared before cyclization takes place.  
 
 
N
RO
RO
R1
OR2
R2O
NH
RO
RO
R1
NH
RO
RO
R1
OR2
R2O
NH
RO
RO
R1
NH
RO
RO
R1
OR
H2/Pt
HCl
HCl
H2/Pt-C
HCl
H2/Pt-C
92 93
94 95
96
 
Scheme 19. Pomeranz-Fritsch-Bobbit cyclization. 
 
Badia´s group46 used optically active benzylamine 98 as the starting material for the 
synthesis of (5S)- and (5R)-hydroxyxylopinine (97a and 97b). The approaches used two 
consecutive classical steps involving the Pictet-Spengler and the Pomeranz-Fritsch-
Bobbitt cyclization. First, amine 98 was converted to tetrahydroisoquinoline 99 under 
the action of formaldehyde/HCl. In the second step, the tetracyclic protoberberine 
carbon skeleton was obtained by cyclization of aminoacetal 100 in concentrated HCl as 
a separable 1:1 mixture of (5R)-97a and (5S)-97b hydroxyxylopinine (see scheme 20). 
 
                                                 
45 M. Bobbitt, J. M. Kiely, K. L. Khanna, R. Eberman,  J. Org. Chem. 1965, 30, 2247–2250. 
46 L. Carrillo, D. Badia, E. Dominguez, E. Anakabe, I. Osante, I. Tellitu, J. L. Vicario, J. Org. Chem. 
1999, 64, 1115–1120. 
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Scheme 20. The synthesis of 5-hydroxyxylopinine (97) by Badia et. al. 
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Figure 5. Structures of (+)-(S)-laudanosine (101) and (–)-(S)-xylopinine (102) 
 
Laudanosine (101) is a substructure of the muscle relaxant atracurium (103). This 
recently developed muscle relaxant contains two quaternary nitrogen atoms in the  
benzyltetrahydroisoquinoline structures. It is used as a complement of tubocurarine (62). 
In addition to enzymatic ester hydrolysis, atracurium (103) is also degraded in the body 
by non-enzymatic E2 Hofmann elimination, which is independent of liver or kidney 
function. Normally, this elimination would require strongly alkaline conditions and a 
high temperature. However, the presence of the ester groups increases the acidity and 
thus facilitates the deprotonation. The elimination can proceed readily under 
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physiological conditions, giving atracurium (103) a half life of about 20 minutes. This is 
particularly valuable when patients have low or atypical pseudocholinesterase enzymes. 
Atracurium (103) contains four chiral centers (including the two quaternary nitrogen 
atoms) and is supplied as a mixture of stereoisomer. The single isomer cisatracurium 
(104) has recently been introduced. This isomer is more potent than the mixture, has a 
slightly longer duration of action, and causes fewer cardiovascular side effects.47 
 
N
H3CO
H3CO
H3CO
H3CO
N
H3CO
H3CO
H3CO
H3CO
O O
O O
O
O O
O
N
OCH3
OCH3
OCH3
OCH3
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OCH3
OCH3
OCH3
H3CCH3
Atracurium (103)
Cisatracurium (104)
CH3 H3C
 
 
Figure 6. Structure of atracurium (103) and cisatracurium (104). 
 
The synthesis of rac-laudanosine (101) has been reported first by Pictet and 
Finkelstein48 using the Bischler-Napieralski cyclization/reduction sequence. Treatment 
of homoveratrylamine (86) and dimethoxyphenylacetic acid (105) with PCl5 and 
subsequent reduction of the dihydroisoquinoline 106 in the presence of HCl/Zn 
furnished the product (rac-laudanosine), which was obtained as an identical compound 
with the reduction product of chloromethylate papaverine (107) (see scheme 20, 107 → 
101). 
                                                 
47 P. M. Dewick,  Medicinal natural products : a biosynthetic approach, 2nd ed., John Wiley & Sons, 
New York, 2002, p. 324. 
48 A. Pictet, M. Finkelstein, Ber. 1909, 42, 1979. 
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Scheme 21. The synthesis of rac-laudanosine (101) by Pictet and Finkelstein. 
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Scheme 22. The synthesis of (–)-(R)-laudanosine (101) by Czarnocki. 
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Czarnocki49 used (+)-L-ascorbic acid (108) as chiral starting material to synthesize (–)-
(R)-laudanosine (101) via Bischler-Napieralski cyclization/diastereoselective reduction. 
Using this method, laudanosine (101) has been synthesized with good enantioselective 
excess. First, (+)-L-ascorbic acid (108) was converted to L-gulano-1,4-lacton (109) by 
catalytic hydrogenation. After treatment with homoveratrylamine (86) at an elevated 
temperature and several subsequent steps including the Bischler-Napieralski reaction 
using PCl5, pentahydroxy compound 110 was obtained. Several further  transformations 
of tetrahydroisoquinoline 110 gave unnatural (–)-(R)-laudanosine (101) with 94% ee 
(Scheme 22). 
H3CO
H3CO
H
N
N
H3CO
H3CO
OCH3
OCH3
CH3
COOR*
PhR* =
H3CO
H3CO OCH3
N
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    K-t-amylate
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H3CO
OCH3
OCH3
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112 α−H   113a
ß- H   113b
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Scheme 23. The synthesis of (–)-(S)-laudanosine (102) and (+)-(S)-xylopinine (102) by 
Comins et.al. 
 
A cyclohexyl-based chiral auxiliary has been used by Comins et.al.50 in concise 
asymmetric synthesis of laudanosine (101) and xylopinine (102). A condensation of the 
                                                 
49 Z. Czarnocki, J. B. Mieczkowski, M. Ziolkowski, Tetrahedron Asymmetry 1996, 7, 2711–2720. 
50 D. L. Comins, P. M. Thakker, M. F. Baevsky, M. M. Badawi, Tetrahedron 1997, 53, 16327–16340. 
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chiral carbamate 111, with vinyl ether 112 gave diastereoisomeric benzylisoquinolines 
113a and 113b in a 83:17 ratio. Unfortunately, the diastereoisomers 113a and 113b 
could not be conveniently separated by chromatography, so the mixture was finally 
reduced with LiAlH4 to give laudanosine (101) in 73% with only 63% ee. Alternatively, 
transformation of the product by treatment with tBuLi/potassium t-amylate and 
subsequent reduction using Red-Al®  afforded xylopinine (102) (Scheme 23). 
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Scheme 24. Several synthetic routes to (–)-(S)-xylopinine (102). 
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Xylopinine (102) is a prototypical member of the protoberberines, a large family of 
naturally occurring alkaloids characterized by a tetracyclic ring skeleton containing a 
tetrahydroisoquinoline core. In higher plant, the “berberine bridge” is formed by the 
enzyme-catalyzed conversion of an N-methyl group in (S)-reticuline (54).51 Xylopinine 
(102) was first isolated from Xylopia discreta (Annonaceae) by J. Schmutz in 1959.52  
 
Several synthesis of xylopinine (102) have been reported. Before xylopinine was 
isolated as a natural product, Corrodi and Hardegger synthesized this molecule by 
heating (–)-tetrahydropapaverine hydrochloride (114) with aqueous formaldehyde.53 
Comins49 and Czarnocki54 used a chiral auxiliary mediated Pictet-Spengler  reaction to 
get the desired configuration at C13a of xylopinine (102). A photochemical cyclization 
strategy using an enatiomerically pure enamide (115) was employed by Kametani.55 
Davis reported the asymmetric synthesis of (−)-(S)-xylopinine (102) using enantiopure 
sulfinimines.56 The benzyl-protected 2-methoxynaphthylsulfinimine (+)-(S)-118 was 
reacted with the lithiated nitrile of 117 affording the major diastereoisomer (–)-(SS,S)-
119 in 68% yield with 96% de. This key intermediate 119 was then converted to (–)-(S)-
xylopinine (102) (Scheme 24).   
 
2.2. RETROSYNTHETIC ANALYSIS 
The S-configuration of C1 of (+)-(S)-laudanosine (101) and C13a of (–)-(S)-xylopinine 
(102) should be constructed by an enantioselective reduction of imine 124, which has 
already been described by Noyori et al. In contrast to the common synthesis of 
benzylisoquinoline alkaloids, the imine 124 was planned to arise from an intramolecular 
hydroamination reaction of amino alkyne 123. Using this approach, the C1–C8a bond 
                                                 
51 For Reviews see: a) T. M. Kutchan, in The Alkaloids: Chemistry and Biology, (Ed.: G. A. Cordell), 
Academic Press, San Diego, 1998, vol. 50, 258–316. b) P. J. Facchini, Annu. Rev. Plant Physiol. Plant 
Mol. Biol. 2001. 52, 29–66. 
52 J. Schmutz, Helv.  Chim. Acta  1959, 335–343. 
53 H. Corrodi, E. H. Hardegger, Helv. Chim. Acta  1956, 889–897. 
54 Z. Czarnocki, Z. Arazny, Heterocycles 1999, 51, 2871–2879. 
55 T. Kametani, N. Takagi, M. Toyota, T. Honda and K. Fukumoto, J. Chem. Soc. Perkin I 1981,        
2830–2834. 
56 F. A. Davis, P. K. Mohanty, J. Org. Chem. 2002, 67, 1290–1296. 
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can be formed by a Sonogashira coupling reaction57 between the aryl iodide 120 and 
alkyne 121. Correspondingly, the typical electrophilic aromatic substitution reaction 
which is usually employed for the formation of the C1–C8a bond of benzylisoquinolines 
can be avoided. An obvious advantage of this strategy is the fact that in contrast to 
electrophilic aromatic substitutions, the Pd-catalyzed Sonogashira coupling is facilitated 
by electron-withdrawing substituents located in the A-ring (Scheme 25).  
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H3CO
N
OCH3
OCH3
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H3CO
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H3CO
I
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N
OCH3101
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CH3
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Scheme 25. Retrosynthesis of both (+)-(S)-laudanosine (101) and (–)-(S)-xylopinine 
(102). 
 
Sonogashira demonstrated that terminal alkynes react smoothly with haloalkenes and 
aryl halides in the presence of catalytic amounts of bis(triphenylphosphine)palladium 
dichloride and cuprous iodide in diethylamine at room temperature. This mild process 
has performed very well in a variety of contexts in organic synthesis. The presumed 
catalytic cycle for this Pd0/CuI-catalyzed coupling of sp- and sp2-carbon atoms is shown 
in scheme 26. Bis(triphenylphosphine)palladium(0), the putative active catalyst, could 
conceivably be formed in situ through sequential copper(I) iodide-catalyzed bis-
                                                 
57 a) K. Sonogashira, Y. Tohda, N. Hagihara, Tetrahedron Lett. 1975, 16, 4467–4470; b) K. Sonogashira, 
in: Comprehensive Organic Synthesis (Eds.: B. M. Trost, I. Fleming), Pergamon Press, Oxford, 1991,   
vol. 3, p. 521–549. 
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alkynylation and reductive elimination reaction (125→126→127). Once formed, the 
highly coordinatively unsaturated 14-electron palladium(0) complex 127 participates in 
an oxidative addition reaction with the aryl- or vinyl halide to the give 16-electron 
palladium(II) complex 128. A cooper(I)-catalyzed alkynylation of 128 then furnishes an 
aryl- or vinyl palladium(II) complex 129. Finally, a terminating reductive elimination 
step liberates the coupling product 130 and regenerates the active palladium catalyst 
127. 
 
 
(Ph3P)2PdCl2
HC CR2
C CR2(PPh3)2Pd
CuI (cat.), Et2NH
Et2NH2Cl
2
R2C C C CR2
(Ph3P)2Pd0
(Ph3P)2Pd
R1
X
(Ph3P)2Pd
R1
C
CR2
HC CR2
CuI/
Et2NH
Et2NH2X
R1C CR2
R1 X
reductive 
elimination
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reductive 
elimination
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128129
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Scheme 26. Catalytic cycle for the Sonogashira reaction. 
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2.3. SYNTHESIS OF AMINO ALKYNES 
Homoveratrylamine (86) and Boc-anhydride were reacted in methanol in the presence of 
the strong base NaOH at room temperature. After purification, the Boc-protected amine 
(131) was isolated in 85% yield. Iodination of the product with iodine in the presence of 
silver trifluoroacetate gave aryl iodide (132) in 93% yield. Because the silver salt is 
relatively expensive, a modified Konigstein procedure,58 using a mixture of iodine and 
HIO3 in methanol/water (3:1), was used in further experiments. This procedure also gave 
the product in a satisfactory yield (79%). Iodoveratrol (135), the desired Sonogashira 
coupling partner, was also syntheiszed by using this modified Konigstein procedure in 
92% yield from veratrol (134).  
H3CO
H3CO
H3CO
H3CO I
c. I2, HIO3
H3CO
H3CO
NH2 H3CO
H3CO
NHBoc H3CO
H3CO
NHBoc
I
a. Boc2O
b1. I2, F3CCOOAg
        or 
b2. I2, HIO3
86
131 132
134 135
Scheme 27. Synthesis of aryl iodides 132 and 135. Reagents and conditions: a. Boc2O 
1.3 equiv, NaOH 2.0 equiv, MeOH, 0°C → 25°C, 18 h, 85%; b1. I2 1.1 equiv, 
F3CCOOAg 1.1 equiv, CH2Cl2, 25°C, 4 h, 93%, b2. I2 0.4 equiv, HIO3 0.2 equiv, 
MeOH/H2O (3:1), 85°C, 48 h, 79%; c. I2 0.4 equiv, HIO3 0.2 equiv, MeOH-H2O (3:1), 
85°C, 48 h, 92%. 
 
In an initial experiment to construct bisarylacetylene 139, aryl iodides 132 and 135 were 
subjected to a one-pot Sonogashira coupling reaction that was reported to give 
bisarylacetylenes from TMS-acetylene and two different aryl iodides.59 Aryl iodide 132 
was first added to a flask containing 6 mol-% PdCl2(PPh3)2 and 10 mol-% CuI. 
Subsequently, 6.0 equivalents of Et3N and TMS-acetylene were added, in order to obtain 
the standard Sonogashira product. Unfortunately, subsequent addition of 1.0 equivalent 
of the second aryl iodide 135, 12.0 equivalents of DBU and 40 mol-% of water did not 
                                                 
58 a) L. F. Tietze, R. Schimpf, Synthesis 1993, 876–880; b) H. O. Wirth, O. Königstein, W. Kern, Justus 
Liebigs Ann. Chem. 1960, 634, 84–104. 
59 M. J. Mio, L. C. Kopel, J. B. Braun, T. L. Gadzikwa, K. M. Hull, R. G. Brisbois, C. J. Markworth, P. A. 
Grieco, Org. Lett. 2002, 4, 3199–3202. 
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result in the formation of the desired bisarylethyne (139). As the product, only aryl 
alkyne 136 was isolated in 81% yield (Scheme 28).  
H3CO
H3CO I
H3CO
H3CO
NHBoc
I
a. Pd(PPh3)2Cl2, CuI,NEt3
Si(CH3)3
H3CO
H3CO
NHBoc
Si(CH3)3
b. DBU, H2O
H3CO
H3CO
NHBoc
OCH3
OCH3
132
136
139
135
Scheme 28. One-pot procedure of synthesis of bisarylacetylene 110. Reagents and 
conditions: a. 6 mol-% PdCl2(PPh3)2, 10 mol-% CuI, NEt3, TMS-acetylene, 25 °C, 18 h; 
b. DBU 12.0 equiv, 40 mol-% H2O, 135, 25 °C, 24 h. 
 
CH3O
CH3O I
CH3O
CH3O
CH3O
CH3O
NHBoc
Si(CH3)3
OCH3
OCH3
CH3O
CH3O
d. PdCl2(PPh3)2,
    CuI, PPh3,
    iPr2NH e. K2CO3
f. Pd Cl2(PPh3)2,
    CuI, PPh3,
    iPr2NH
CH3O
CH3O
NHBoc
I
+ 121
135 140 121
132 139
Scheme 29. Synthesis of alkyne 139. Reagents and conditions: d. 2 mol-% 
PdCl2(PPh3)2, 4 mol-% CuI, 4 mol-% PPh3, iPr2NH, 25°C, 16 h, 92%; e. K2CO3 0.1 
equiv, MeOH, 25°C, 16 h, 82%; f. 2 mol-% PdCl2(PPh3)2, 4 mol-% CuI, 4 mol-% PPh3, 
iPr2NH, 25°C, 16 h, 95%. 
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Alternatively, the bisarylacetylene 139 was then planned to be synthesized step by step. 
Coupling between TMS-acetylene and iodoveratrol (135) under standard Sonogashira 
conditions afforded TMS-protected alkyne 140 in 92% yield. Subsequently, removal of 
the TMS group of arylalkyne 140 under basic conditions gave terminal alkyne 121 in 
82% yield. Then, a second coupling reaction between alkyne 121 and 132 using the 
standard Sonogashira conditions gave the Boc-protected amino alkyne 139 in 95% yield 
(Scheme 29).  
 
Surprisingly, cleavage of the Boc-group of 139 to afford the desired amino alkyne 123 
failed. The usual procedure using trifluoroacetic acid at room temperature gave a dark 
brown solution. According to TLC, there was still protected amine left in solution after 6 
h. However, no significant product formation could be observed. The use of AlCl3 as 
Lewis-acid catalyst for the deprotetion also resulted in a dark brown solution and no 
amine formation. 
H3CO
H3CO
NHBoc
OCH3
OCH3
a. K2CO3
139
H3CO
H3CO
NH2
OCH3
OCH3
H3CO
H3CO
NHBoc
Si(CH3)3
H3CO
H3CO
NHBoc
H
H3CO
H3CO
NH2
H
b. F3CCOOH
136 141
142
123
F3CCOOH
or
AlCl3
 
Scheme 30. Deprotection of Boc-group. Reagents and condition: a. K2CO3 0.1 equiv, 
MeOH, 25°C, 3 h, 88%; b. F3CCOOH 6.5 equiv, CH2Cl2, 25°C, 20 h, 86%. 
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In contrast, amino alkyne 142 can easily be obtained from 141 under standard condition 
for the deprotection of Boc-groups. The electron rich alkyne 139, which is substituted by 
two donating electron rich 3,4-dimethoxyphenyl-groups, might be protonated under the 
reaction conditions. Then, the protonated form can cause side reactions to give an 
unseparable mixture of products. A neural deprotection method (for example: using 
TBDPSOTf or TMSI) was avoided since CO2 is released. CO2 should contact in neutral 
condition with primary amines to form carbamides. So we decided to use the 
trifluoroacetamide protecting group. 
 
H3CO
H3CO
NH2 H3CO
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I
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d. KOH
86 143
144145
123
 
 
Scheme 31. Synthesis of amino alkyne 123. Reagents and conditions: a. F3CCOOEt 1.1 
equiv, THF, 25°C, 4 h; b. I2 0.4 equiv, HIO3 0.2 equiv, MeOH/H2O (3:1), 85°C, 48 h, 
93% (two steps); c. 4 mol-% PdCl2(PPh3)2, 8 mol-% CuI, 8 mol-% PPh3, iPr2NH, 25 °C, 
16 h, 84%; d. KOH 10.0 equiv, MeOH, 25 °C, 8 h, 90%. 
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The synthesis of the amino alkyne 123 was accomplished as depicted in scheme 31. The 
reaction of homoveratrylamine 86 with ethyl trifluoroacetate in THF at 25°C gave the N-
protected trifluoroacetaamide 143 cleanly. After evaporation of the solvent, without 
further purification, the product 143 was obtained in high purity. Subsequently, aryl 
amine 143 was iodinated to give 144 in the presence of I2 and HIO3 at 85°C in a mixture 
of water and methanol (modified Konigstein method) in 93% yield. Aryl iodide 144 was 
then subjected to the standard Sonogashira conditions to give the TFA-protected amino 
alkyne 145 in 84% yield. In this context, it is worth mentioning that in alkyne 145 the 
C1-C8a bond (vide supra) has already been established. Liberation of the NH2-group 
under basic condition (KOH, MeOH) delivered amino alkyne 123 in 90% yield. 
 
2.4. INTRAMOLECULAR HYDROAMINATION CYCLIZATION 
The key intermediate 123 was subjected to the hydroamination reactions at 105°C in 
toluene in the presence of 5 mol-% of a Ti-complex as the catalyst. The reaction was 
stopped after 48 h and a subsequent reduction performed with NaCNBH3 and ZnCl2 in 
methanol at 25°C for 20 h was performed. As can be seen from table 1 (entry 1-4), under 
these conditions, the desired product 146 was only obtained in 34% yield, when 
Cp2TiMe2 was used as the catalyst. The product was not detected, when Ind2TiMe2, 
Ti(NMe2)4 or (rac-EBTHI)TiMe2 were used. These results showed that for this reaction 
it was necessary to find a special and optimized conditions. Norlaudanosine (rac-146) 
was obtained from amino alkyne 123 in 96% yield under hydroamination conditions in 
the presence 10 mol-% Cp2TiMe2 after 16 h of reaction time. 
 
To produce imine 124, the key intermediate 123 was subjected in the same conditions. 
The hydroamination reaction proceeded smoothly within 16 h in 98% yield after 
chromatography. It is necessary to note that aqueous workup should be avoided because 
the imine product is easily converted to the more stable enamine under aqueous 
conditions.  
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Scheme 32. Hydroamination of amino alkyne 123. Reagents and conditions: a. 10 mol-
% Cp2TiMe2, toluene, 105°C, 16 h, 98%; b. 10 mol-% Cp2TiMe2, toluene, 105°C, 16 h; 
then NaCNBH3 2.0 equiv, ZnCl2 1.0 equiv, MeOH, 25°C, 20 h, 96% 
 
Table 1. Hydroamination of amino alkyne (123). 
Entry Mol- % Catalyst Time Yields of 124 
(%) 
1 5 Cp2TiMe2 48 h 34a 
2 5 Ind2TiMe2 48 h - 
3 5 Ti (NMe2)4 48 h - 
4 5 (rac-EBTHI)TiMe2 48 h - 
5 10 Cp2TiMe2 16 h 96 
6 20 CsOH•H2O 7 d not isolated 
7 40 CsOH•H2O 7 d 66b 
a. Product 146 after reduction with NaCNBH3/ZnCl2; b. as a 1:2 mixture imine and enamine. 
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Knochel et. al.60 reported that CsOH•H2O catalyzed hydroaminations of alkynes in NMP 
at 90-120°C. A corresponding cyclization of amino alkyne 123 took place in the 
presence of 20 mol-% CsOH•H2O in NMP at 150°. However, according to TLC, the 
reaction was not completed even after 7 days under the reaction conditions and the 
product could not be isolated by flash chromatography. However, when the catalyst of 
CsOH•H2O was 40 mol-%, the product could be isolated in 66% yield as a 1:2 mixture 
of imine and enamine. 
 
 
The enantioselective transfer hydrogenation under Noyori conditions employing 1 mol-
% (η6-p-cymene)[(1R,2R)-N-(p-tolylsulfonyl)-1,2-diphenylethylenediamine]RuCl  (81b) 
as the catalyst in an azeotropic mixture of formic acid and triethylamine furnished 
norlaudanosine (146) in 92% yield with 93% ee (S-configuration), in good agreement 
with Noyori´s results (scheme 33).  
 
Using formic acid as a stable organic hydrogen donor is an alternative to the flammable 
molecular hydrogen. Although Ru(II)-complexes are known to catalyze the reversible 
process, 
HCO2H H2 CO2+
Ru-cat.
 
the reduction of the imine is a result of transfer hydrogenation by formic acid. 
Interference of molecular hydrogen does not take place. 
 
A chiral Ru hydride 147 is formed and it is assumed that the hydrogen transfer occurs 
via metal-ligand bifunctional catalysis. The N-H linkage may stabilize a transition state 
148 by formation of a hydrogen bond to the nitrogen atom. The stereochemical outcome 
of the reaction is determined by discrimination of the enantiofaces of the imine double 
bond of the cyclic imine. 
 
                                                 
60 D. Tzalis, C. Koradin, P. Knochel, Tetrehedron Lett. 1999, 40, 6193-6195. 
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Figure 7. Asymmetric Ru-catalyzed transfer hydrogenation. 
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Scheme 33. Synthesis of (+)-(S)-laudanosine (101) and (–)-(S)-xylopinine (102). 
Reagents and conditions: a. 1 mol-% (R,R)-Ru-cat. 81b, HCOOH : NEt3 (5:2), DMF, 
25°C, 7 h, 92%, 93% ee; b. CH2O, NaBH4 10 equiv, H2O, MeOH, 25°C, 2 h, 99%; c. 
CH2O, F3CCOOH, 25°C, 16 h, 82%. 
 
The final step of the synthesis of (+)-(S)-laudanosine (101) was the methylation of the 
N-2 atom of norlaudanosine 146. Treatment of 146 with formaldehyde (37%) and 
subsequent borohydride-reduction at 25 °C (16 h) furnished (+)-(S)-laudanosine (101) in 
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99% yield. Optical rotation of the product was [ ]25Dα = + 87 (c = 0.7, in ethanol) (Lit.61 
[ ]25Dα  = + 103, in ethanol). 
 
Alternatively, the formation of a berberin bridge from 146 by regioselective Pictet-
Spengler reaction employing aqueous formaldehyde (37%) and trifluoroacetic acid 
afforded (–)-(S)-xylopinine (102) in 82% yield. Optical rotation of product was [ ]25Dα  =  
-262 (c = 0.1, in chloroform) (Lit.50 [ ]25Dα  = - 297, in chloroform). 
 
2.5. ENATIOSELECTIVE ONE-POT SYNTHESIS OF ISOQUINOLINE BY A 
HYDROAMINATION/ ENATIOSELECTIVE REDUCTION SEQUENCE 
Modern synthesis design demands high efficiency in terms of minimization of synthetic 
steps together with maximization of complexity. As a result, one-pot procedures have 
been developed to avoid the decrease of yields caused by workup and purification. With 
such procedures, intermediates do not need to be stable enough for isolation, because 
they are quickly transformed by a subsequent reaction into the desired products. 
  
In the Doye group, the borohydride reduction system NaCNBH3, ZnCl262 has become 
the method of choise to reduce imines which are obtained by hydroamination reaction of 
alkynes to the desired amines. Both reactions can be conveniently performed as a one-
pot operation. Using this two-steps method, amino alkyne 123 was converted into rac-
norlaudanosine 146 in 96% yield.  
 
Alternatively, the amino alkyne 123 could also be cyclized to give rac-norlaudanosine 
146 in 79% yield using a one pot protocol consisting of Cp2TiMe2-catalyzed 
hydroamination/hydrosilylation sequence.63  
 
                                                 
61 Römpp Lexikon Naturstoffe, 10th ed. (Eds.: B. Fugmann, S. Lang-Fugmann, W. Steglich), Georg 
Thieme Verlag, Stuttgart, 1997, p. 79–80. 
62 S. Kim, C. H. Oh, J. S. Ahn, Y. J. Kim, J. Org. Chem. 1985, 50, 1927–1932. 
63 A. Heutling, F. Pohlki, I. Bytschkov, S. Doye, Angew. Chem. 2005, 117,  3011–3013. 
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CH3O
CH3O
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OCH3
OCH3
CH3O
CH3O
NH
OCH3
OCH3
a. 10 mol-% Cp2TiMe2
b. PhSiH, piperidine, MeOH
123 rac-146  
Scheme 34. Hydroamination/hydrosilylation of amino alkyne 123. Reagents and 
conditions: a. 10 mol-% Cp2TiMe2, toluene, 105°C, 16 h; b. PhSiH3 equiv, 40 mol-% 
piperidine, 40 mol-% MeOH, 105°, 24 h, 79% (two steps). 
 
Inspired by the work of Odom who has reported that Ti-catalyzed hydroaminations 
could be followed by further transformations catalyzed by other metals in one-pot, the 
asymmetric transfer hydrogenation by Noyori´s procedure was attempted to be 
employed subsequently to the Ti-catalyzed hydroamination reaction. Amino alkyne 123 
was subjected to 10 mol-% Cp2TiMe2 in toluene at 105°C until amino alkyne 123 was 
completely consumed. The Noyori´s reduction system (1 mol-% (R,R)-Ru-cat 81b, 
NEt3:HCOOH = 5:2,  DMF) was then directly added to the hydromination reaction 
mixture at room temperature.  However, after further stirring for 48 h, the desired amine 
product was not observed according to TLC. The titanium catalyst might be interfering 
with the Ruthenium–catalyzed transfer hydrogenation process. The same result has also 
been reported by Siebeneicher,64 even with high concentrations of the Ru-catalyst. 
Consequently, the Ti-catalyst must be decomposed before reduction.  
 
Since Cp2TiMe2 can be consumed by the methylenation of amides,65 we thought that if 
the hydroamination mixture is quenched with DMF (solvent for the reduction process) 
followed by heating for several hours, the reduction process should work afterwards. 
Correspondingly, DMF was added to the hydroamination mixture and then the mixture 
was heated to 65°C for 24 h. Subsequently, under Noyori´s conditions the 
dihydroisoquinoline 124 could be reduced completely into (S)-norlaudanosine (146). 
After purification by flash chromatography, (S)-norlaudanosine (146) was isolated in 
61% yield and, unfortunately, with only 26% ee. 
                                                 
64 H. Siebeneicher, Dissertation,  Universität Hannover, 2004, p. 78. 
65 N. A. Petasis, S-P. Lu, Tetrahedron Lett. 1995, 36, 2393–2396. 
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Xiao et. al.66 reported a recent modification of the Noyori system. He described a 
degassed aqueous system in the presence of HCOONa as the hydrogen source. With this 
method, unfunctionalized aromatic ketones were easily reduced into alcohols by a Ru-
catalyzed transfer-hydrogenation with HCOONa in neat water with good to excellent 
enantioselectivities. A one-pot hydroamination/modified asymmetric transfer 
hydrogenation sequence was performed with the amino alkyne 123 as starting material. 
Cyclization using Cp2TiMe2 as the catalyst was complete after 16 h (10 mol-% 
Cp2TiMe2, toluene, 105 °C). Subsequently, water containing (R,R)-Ru-catalyst 81b and 
HCOONa were added at 40°C. After the resulting mixture had been degassed three 
times, the solution was allowed to react at 40°C for 7 h. After the solution had been 
cooled to 25°C and a worked up with ether, (S)-norlaudanosine (146) was isolated by 
flash chromatography in 93% yield and with 60% ee (Scheme 35).  
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Scheme 35. One-pot procedure of Cp2TiMe2-catalyzed hydroamination/asymmetric Ru-
catalyzed transfer hydrogenation reduction.  
 
 
                                                 
66 X. Li, X. Wu, W. Cheng, F. E. Hancock, F. King, J. Xiao, Org. Lett. 2004, 6, 3321–3324. 
  
 
 
 
 
 
III     INTRAMOLECULAR HYDROAMINATION OF ALKYNES AS A GENERAL 
METHOD FOR THE SYNTHESIS OF  BENZYLISOQUINOLINES 
 
 
 
 
3.1. INTRODUCTION 
 
The successful synthesis of (+)-(S)-laudanosine (101) and (–)-(S)-xylopinine (102) 
motivated us to apply the intramolecular hydroamination of alkynes towards the 
synthesis of benzylisoquinolines with an electron-deficient A-ring. To our best 
knowledge today, there are not simple methods to synthesize these molecules. We 
choose fluorinated benzylisoquinolines as molecular targets. 
  
The organofluorine chemistry contributes to great advances in modern medical 
treatments. With the aid of the known influence of a fluorine atom on physical, chemical 
and biological phenomena, therapeutic efficacy has been increased and pharmacological 
properties have been improved. A significant finding in the late 1950s was that 5-fluoro 
urasil (5-FU) 148 exhibits significant tumor-inhibiting activity. Since then, 5-FU (148) 
has been employed with success for treatment of human breast cancer and several other 
types of malignancies.67 A wide variety of effective fluoromedicines have been 
                                                 
67 T. Hiyama, Organofluoride Compounds Chemistry and Application, Springer, Berlin, 2000, p. 137. 
GENERAL SYNTHESIS OF BENZYLISOQUINOLINE 
 43
developed and put into the pharmaceutical marketplace, including steroid- and non-
steroid antiviral agents, antihypertensive agents and central nervous system drugs for the 
management of mental illnesses such as depression and psychoses. Recently, some 
fluorinated isoquinolines have been patented as compounds, which are useful as 
modulators of chemokine receptor activity. Tetrahydropyranyl cyclopentyl 
tetrahydroisoquinoline 150 is the simplest member of this interesting pharmacologically 
class of molecules.68 
 
 
HN
N
H
F
O
O
149
N
F3C
O
NH
i-Pr
O
150  
 
Figure 8.  5-Fluorouracil and a fluorinated isoquinoline. 
 
Mitscher et. al.69 demonstrated the synthesis of 6,7.difluoro dihydroisoquinoline 151 
employing the modified Bischler-Napieralski conditions. Reaction of 152 with oxalyl 
chloride followed by cyclization in the presence of iron(III) chloride produced the oxalyl 
ester amide 154 in 85% yield for the two steps. The success of this process was via the 
presumed cyclic oxazolidinedione intermediate which forms a highly reactive N-
acyliminium ion 153 further polarized in the presence of iron(III) chloride.70 Compound 
154 was immediately hydrolyzed and dehydrated with acidic methanol to give the 
previously elusive 151 in 73% yield.  
                                                 
68 R. Jiao, S. D. Goble, S. G. Mills, G. Morriello, A. Pasternak, L. Yang, C. Zhou, G. Butora, S. 
Kothandaraman, D. Guiadeen, C. Moyes,  PCT Int. Appl. 2003, WO 2003-US13121 20030425. 
69 R. A. Fecik, P. Devasthale, S. Pillai, A. Keschavarz-Shokri, L. Shen, L. A. Mitscher, J. Med. Chem. 
2005, 48, 1229-1236. 
70 R. D. Larsen, R. A. Reamer, E. G. Corley, P. Davis, E. J. J. Grabowski, P. J. Reider, I, Shinkai, J. Org. 
Chem. 1991, 56, 6034-6038. 
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Scheme 36. The synthesis of dihydroisoquinoline 151. 
 
3.2. GENERAL RETROSYNTHESIS ANALYSIS OF BENZYLISOQUINOLINES  
NH2
N
CH3
X
CN +
X
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R1
R1R1
R2
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R1, R2 = EWG or EDG
X = Br
155
156
157159
A B
158
1
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45
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Scheme 37. Retrosynthesis of benzylisoquinolines. 
 
In analogy to the synthesis of laudanosine (101), the synthesis of benzylisoquinoline 
derivatives with electron-deficient A-rings commenced with the preparation of the key 
intermediate amino alkyne (156), as shown in scheme 37. The significant processes in 
this context are the cross coupling between the aryl bromide 157 and the terminal alkyne 
158 which can be achieved by a Sonogashira reaction, and subsequently an 
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intramolecular Ti-catalyzed hydroamination. The coupling partner o-bromo-benzylnitrile 
157 should be accessable via cyanation of o-bromo benzylalcohol (159). 
 
 3.3. SYNTHESIS OF 6-TRIFLUOROMETHYLBENZYLISOQUINOLINE 
The first goal in this synthesis was to obtain an o-halogenated-benzylnitrile. In principle, 
this could be achieved by halogenation of a deactivated aromatic 160 (scheme 38). 
Usual methods for this transformation are carried out under harsh conditions. A 
convenient method, however, is a directed ortho-lithiation, followed by a quenching 
with an electrophile. Several examples have been reported using this method for the 
metalation of EWG-substituted aromatic system.71 
 
Seebach has reported the synthesis of several ortho-substituted benzylalcohols via 
formation of ortho-lithiated benzyloxylithium compounds using a direct ortho lithiation 
procedure.72 We attempted to iodinate m-trifluoromethyl benzylacohol (160), employing 
Seebach´s procedure (nBuLi 2.0 equiv, TMEDA 2.0 equiv, petrolether, reflux, 16 h). 
The resulting mixture was cooled to −78°C and then treated with an iodine solution in 
THF. After the mixture was allowed to reach room temperature, it was found that the  
desired product 161 was not obtained. The unsuccessful trial of this method was 
probably caused by side reactions of the lithium alkoxide group, which tends to 
aggregate with themselves to form oligomeric or polymeric clusters. The oxygen-
functionalized side chain is thus converted into a huge and voluminous substituent that 
sterically shields the neighboring ortho position.73 
 
F3C
OH
F3C
I
OH
a. nBuLi, TMEDA
b. I2
160 161  
Scheme 38. Application of Seebach´s procedure to the synthesis of 161. 
                                                 
71 For reviews, see: a) V. Snieckus, Chem. Rev. 1990, 90, 879–933; b) C. G. Hartung, V. Snieckus, in 
Modern Arene Chemistry (Ed.: D. Astruc), VCH, Weinheim, 2002, p. 330. 
72 N. Meyer, D. Seebach, Angew. Chem. 1978, 90, 553–554. 
73 For further studies of a similar problem, see: E. Marzi, A. Spitalari, F. Mongin, M. Schlosser, Eur. J. 
Org. Chem. 2002, 2508–2517. 
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Since the directed ortho-lithiation strategy starting from benzylacohol 160 was 
unsuccessful, p-bromo-trifluorotoluene (162) was chosen as the starting material. We 
thought that removing the benzylic moiety could facilitate the directed ortho lithiation 
and avoid any aggregation problems. As subsequent reaction with formaldehyde should 
give the desired o-halogenated-benzylalcohol 163. Treatment of p-bromo-
trifluorotoluene (162) with nBuLi and TMEDA followed by the addition of monomeric 
formaldehyde in THF did not give the desired product. Variation of the temperature did 
not improve the results. 
 
Table 2. Functionalization of aryl bromide 162 via directed ortho-lithiation. 
F3C F3C
Br
a. nBuLi, TMEDA
b. E
Br
E
162 163  
 
 Reagent Temperature 
(°C) 
Electrophile Yields (%) 
1 nBuLi, THF -78 HCHO - 
2 nBuLi, THF -20 HCHO - 
3 nBuLi/TMEDA, THF -78 HCHO - 
4 nBuLi/TMEDA, THF -20 HCHO - 
5 nBuLi/TMEDA, THF -78 CO2 17 
6 nBuLi/TMEDA, THF -78 I2 60* 
7 nBuLi/TMEDA, THF -20 I2 63* 
* As a mixture (3:2) with starting material. 
 
In contrast to the results obtained with formaldehyde, reactions with CO2 or I2, took 
place succesfully, although with poor yields. The very poor yield obtained after 
treatment with CO2 might be evoked by wet CO2 granula. A better yield was obtained 
when I2 was employed as the electrophile. Unfortunately, the obtained mixture between 
product 163 and starting material 162 could not be separated by flash chromatography or 
vacuum distillation.  
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We choose an oxidative aromatic iodination procedure by Lulinski and Skulsky74 to 
obtain 3-iodo-4-bromo-trifluorotoluene (164). Deactivated aromatic compounds can be 
iodinated with an anhydrous system of I2/NaIO4/acetic anhydride/glacial acetic acid, 
acidified with conc. sulfuric acid. The Author suggested that this reaction follows: 
 
14 Ar - H + 4 I2 + 6 NaIO4 + 24 Ac2O + 17 H2SO4 14 Ar -ISO4 + 3 Na2SO4 + 48 AcOH
AcOH/Ac2O
 
 
The anhydrous and strongly acidic conditions are indispensable to attain the possible 
highest yield of the assumed organic iodine (III) intermediates, Ar-ISO4 or O4SI-Ar-
ISO4 (undesired product) derived from the reacted deactivated arenes by their 
electrophilic substitution with I3+. After completion of the main iodination reactions, the 
resulting reaction mixtures were poured into an excess of aqueous Na2SO3 solution 
(which also destroys the rest of iodine and any oxidizing species). 
 
Ar-ISO4 + Na2SO3 + H2O Ar-I + Na2SO4 + H2SO4  
 
The treatment of p-bromo-trifluorotoluene (162) under these conditions, surprisingly, 
gave 4-bromo-3-iodo-trifluorotoluene 164 in 96% yield with 0.5% impurity of 3,5-
diiodo-4-bromo-trifluorotoluene (165). 
F3C
Br
I2, Na2IO4
Ac2O, AcOH,
H2SO2
F3C
Br
I F3C
I
I
Br
+
impurity
162 164 465
 
Scheme 39. Iodination of p-bromo-trifluorotoluene (162). Reagents and condition: I2 1.1 
equiv, NaIO4 1.1 equiv, CH3COOH, (CH3CO)2O, H2SO4, 5→25°C, 21 h, 96%. 
 
                                                 
74 P. Lulinski, L. Skulski, Bull. Chem. Soc. Jpn. 2000, 73, 951–956. 
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At this stage, a chemoselective halogen-magnesium exchange by Knochel,75  followed 
by the addition to formaldehyde seems to be a convenient way to obtain o-bromo-
benzylalcohol derivatives (167). Treatment of o-bromo-aryliodide 164 with 1.0 
equivalent of iPrMgCl•LiCl, followed by quenching the resultant aryl magnesium 
derivative 166 with freshly distilled monomeric formaldehyde in THF76 at 40°C and 
aqueous workup provided the expected o-bromo-benzylalcohol 167 in 72% yield. 
Alternatively, using CO2 as the electrophile, o-bromo benzoic acid derivative 168 was 
obtained in only 34% yield. The carboxylic group of 168 was then reduced easily with 
LiAlH4 to give 168 in 62% yield. 
F3C
Br
I F3C
Br
MgCl
F3C
Br
OH
F3C
Br
OH
O
a. iPrMgCl·LiCl b. HCHO
c. CO2 d. LiAlH4
164 166
167
168  
Scheme 40. Synthesis of fragment 167. Reagents and conditions: a. iPrMgCl•LiCl in 
THF 1.0 equiv, - 20°C, 2 h; b. HCHO in THF 1.1 equiv, - 20°C, 1 h, 72%; c. CO2 
granule, - 20°C, 1 h, 34%; d. LiAlH4 2.2 equiv, ether, 25°C, 3 h, 62%.  
 
With the alcohol group in the right place, attempts could begin to substitute the alcohol 
group by a nitrile group. It was desirable to perform this conversion in a single step, in 
order to avoid a second process at the benzylic position. Initially, we chose a simple 
procedure reported by Davis and Untch,77 using NaCN/Me3SiCl and a catalytic amount 
of NaI in DMF/CH3CN, to be employed to the benzyl alcohol 167. Unfortunately, this 
procedure did not give the desired product. Alternatively, we focused on a standard 
procedure for the transformation of an alcohol. The benzylic alcohol 167 was first 
                                                 
75 For an example of a chemoselective halogen-magnesium exchange, see: C-Y. Liu, P Knochel, Org. Lett. 
2005, 7, 2543–2546. 
76 Preparation of monomeric formaldehyde in THF, see: M. Schlosser, D. Coffinet, Synthesis 1971, 380–
381. 
77 R. Davis, K. G. Untch, J. Org. Chem .Soc. 1981, 46, 2985–2987. 
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transformed into the bromide 169, by reaction with PBr3 in 69% yield. Nucleophilic 
substitution employing bromobenzyl derivative 169 and NaCN in DMSO afforded o-
bromo-benzylnitrile 170 in 62% yield. 
 
F3C
Br
OH
F3C
Br
Br
F3C
Br
CNa. PBr3
b. NaCN,
    DMSO
167 169 170
Scheme 41. Transformation of the alcohol group to a nitrile group. Reagents and 
conditions: a. PBr3 0.5 equiv, CH2Cl2, 25°C, 16 h, 69%; b. NaCN 2.0 equiv, DMSO, 90 
→ 50°C, 62%.  
 
F3C
Br
CN
OCH3
OCH3
+
F3C CN
OCH3
OCH3
a. Pd(PH3)2Cl2
    PPh3, CuI
    iPr2NH
    DMF, 85°C
b. LiAlH4·AlCl3
F3C
OCH3
OCH3
NH2
170 121 171
172
Scheme 42. Synthesis of amino alkyne 176. Reagents and conditions: a. 4 mol-% 
Pd(PPh3)2Cl2, 8 mol-% PPh3, 8 mol-% CuI, iPrNH2, DMF, 85°C, 16 h, 96 %; b. 
LiAlH4•AlCl3 1.0 equiv, ether, 25°C, 2 h, 93%.  
 
The synthesis of the key intermediate amino alkyne 172 from 170 required a cross 
coupling with the terminal alkyne 121 under Sonogashira conditions. Under the standard 
conditions (4 mol-% Pd(PPh3)2Cl2, 8 mol-% PPh3, 8 mol-% CuI, iPrNH2, DMF, 85°C, 
16 h), bisarylacetylene 171 was obtained in 96% yield. It is important to note that with 
the arylbromide as the coupling partner, DMF was found to be the best solvent for the 
cross coupling reactions.78 Finally, amino alkyne 172 was obtained in 93% yield by a  
                                                 
78 a) I. Saito, K. Yamaguchi, R. Nagata, E. Murahashi, Tetrahedron Lett. 1990, 31, 7469–7472; b) F. 
Makra, J. C. Rohloff, A.V. Muehldorf, J. Link, Tetrahedron Lett. 1995, 36, 6815–6818; c) D. H. 
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reduction of the nitrile using a strong hydride reducing agent (LiAlCH4·AlCl3, ether, 2 
h).  
 
The tetrahydroisoquinoline 173 was formed by cyclization of amino alkyne 172. The 
key intermediate 172 was subjected to an intramolecular hydroamination reaction 
employing 5 mol-% Ind2TiMe2 as the catalyst in toluene at 110°C for 16 h. 
Subsequently, reduction of the imine using the hydride reagent NaCNBH3, ZnCl2 
afforded tetrahydroisoquinoline 173 in 96% yield. Finally, methylation of the amino 
group of 173 applying a reductive amination protocol with formaldehyde 37% and 
NaBH4, furnished CF3-substituted benzylisoquinoline 174 in 69% yield. 
 
F3C
OCH3
OCH3
NH2 F3C
NH
OCH3
OCH3
F3C
N
OCH3
OCH3
CH3
a. Ind2TiMe2
b. NaCNBH3, ZnCl2
c. HCHO
    NaBH4
172 173 174
 
Scheme 43. The synthesis of tetrabenzylisoquinoline 174. Reagents and conditions: a. 5  
mol-% Ind2TiMe2, toluene, 110°C, 16 h; b. NaCNBH3 2.0 equiv, ZnCl2 1.0 equiv, 
MeOH, 25°C, 20 h, 96% (two steps); c. CH2O, NaBH4 10 equiv, H2O, MeOH, 25 °C, 2 
h, 68%. 
 
3.4. SYNTHESIS OF 6,7-DIFLUOROBENZYLISOQUINOLINE 
With the experience obtained in the synthesis of amino alkyne 172, we used the same 
conditions to synthesize amino alkyne 180 from commercially available 2-bromo-4,5-
difluorobenzoic acid 175 (see scheme 44). First, the carboxylic group was reduced using 
LiAlH4 to furnish benzylalcohol 176 in 59% yield. Treatment of benzylalcohol 176 with 
PBr3 transformed the alcohol group into the bromide group to give benzyl bromide 177 
in 94% yield. Nucleophilic substitution using benzylbromide 177 and NaCN in DMSO 
furnished 2-bromo-4,5-difluorobenzylnitrile  (178)  in  58% yield.   
                                                                                                                                                
Turkenburg, A. A. Antipov, M. B. Thathagar, G. Rothenberg, G. B. Sukhorukov, E. Eiser, Phys. Chem. 
Chem. Phys. 2005, 7, 2237–2240. 
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Scheme 44. Synthesis of tetrahydrobenzylisoquinoline 182. Reagents and conditions: a. 
LiAlH4 1.1 equiv, ether, 25°C, 2 h, 59%; b. PBr3 0.5 equiv, CH2Cl2, 25°C, 24 h, 94%; c. 
NaCN 2.0 equiv, DMSO, 90→50°C, 58%; d. 4 mol-% PdCl2(PPh3)2, 8 mol-% CuI, 8 
mol-% PPh3, iPr2NH, DMF, 80°C, 16 h, 79%; e. LiAlH4•AlCl3 1.0 equiv, ether, 25°C, 2 
h, 91%; f. 5 mol-% Ind2TiMe2, toluene, 110°C, 16 h; g. NaCNBH3 2.0 equiv, ZnCl2 1.0 
equiv, MeOH, 25°C, 20 h, 96% (two steps); h. CH2O, NaBH3, H2O, MeOH, 25°C, 2 h, 
84%. 
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The  arylbromide 178 was then coupled with alkyne 121 under Sonogashira conditions 
to give alkyne nitrile 179 in 79% yield. Finally, the key intermediate amino alkyne 180 
was obtained after reduction with LiAlH4·AlCl3 in 91% yield.  
 
The key intermediate 180 was then subjected to an intramolecular hydroamination 
reaction employing 5 mol-% Ind2TiMe2 as the catalyst in toluene at 110°C for 16 h. 
Subsequently, reduction of the imine using hydride reagent NaCNBH3, ZnCl2 afforded 
tetrahydroisoquinoline 181 in 96% yield over two steps. Finally, the methylation of the 
amino group of 182 using a reductive amination protocol with formaldehyde 37% and 
NaBH4, furnished benzylisoquinoline 182 in 84% yield. 
 
3.5. SYNTHESIS OF 3´,4´-DEDIMETHOXYNORLAUDANOSINE 
During the synthesis of laudanosine (101) we had already synthesize aryliodide 144. 
With this aryl iodide in hand, another alkyne 184 was synthesized from phenylacetylene 
183 under the standard Sonogashira conditions (2 mol-% Pd(PPh3)2Cl2, 8 mol-% PPh3, 8 
mol-% CuI, iPr2NH, 25°C, 16 h) in 81% yield. Liberation of the NH2-group under basic 
conditions (KOH, MeOH, H2O, 25°C, 20 h) delivered amino alkyne 185 in 83% yield.  
 
H3CO
H3CO
H
N
I
CF3
O
CH3O
CH3O
H
N
PdCl2(PPh3)2, CuI, PPh3
iPr2NH
+ 183
CF3
O
CH3O
CH3O
NH2
d. KOH
144
183 184
185
 
Scheme 45. Synthesis of amino alkyne 185. Reagents and conditions: a. 4 mol-% 
PdCl2(PPh3)2, 8 mol-% CuI, 8 mol-% PPh3, iPr2NH, 25°C, 16 h, 81%; d. KOH 10.0 
equiv, MeOH, 25°C, 8 h, 83%. 
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The key intermediate 185 was subjected to an intramolecular hydroamination reaction 
employing 10 mol-% Cp2TiMe2 as the catalyst in toluene at 110°C for 16 h, and 
subsequently, reduction of the imine using hydride reagent NaCNBH3, ZnCl2 afforded 
tetrahydroisoquinoline 186 in 96% yield over two steps. 
 
186
H3CO NH2 H3CO
NH
a. 10 mol-%Cp2TiMe2
b. NaCNBH3, ZnCl2
H3CO H3CO
185
 
Scheme 46. Synthesis of tetrahydrobenzylisoquinoline 186. Reagents and conditions: a. 
10 mol-% Cp2TiMe2, toluene, 110°C, 16 h; b. NaCNBH3 2.0 equiv, ZnCl2 1.0 equiv, 
MeOH, 25°C, 20 h, 82% (two steps). 
 
3.6. ATTEMPS TO SYNTHESIZE OF SALSOLIDINE 
Starting from amino alkyne 142, we attempted to synthesize salsolidine (76). The amino 
alkyne 142 was subjected to hydroamination conditions in the presence of 10 mol-% 
Cp2TiMe2 at 105°C for 24 h. However, after a standard reduction in the presence 
NaCNBH3 and ZnCl2, we did not find the desired product of 76 by flash 
chromatography. The same result was obtained, when 20 mol-% Cp2TiMe2 was 
employed. 
 
CH3O
CH3O
NH2
NH
H3CO
H3CO
a. cat. Cp2TiMe2
b. NaCNBH3, ZnCl2
142 rac-76  
Scheme 47. Attempts to synthesize salsolidine (76) using a Ti-catalyzed 
hydroamination. 
  
 
 
 
 
 
IV  SUMMARY 
 
 
 
 
 
We have demonstrated a new and general method for the synthesis of 
benzylisoquinolines. The Sonogashira reaction and an intramolecular alkyne-
hydroamination are used as key steps in our strategy. Using this new method, 
benzylisoquinolines containing both electron-rich and electron-deficient A-rings can be 
synthesized successfully.  
 
The attempts to synthesize (–)-(S)-laudanosine (101) and (+)-(S)-xylopinine (102) were 
successful in 7 steps from commercially available homoveratylamine (86) in 62% and 
51% yields, respectively. The key intermediate amino alkyne 123 was accessed easily by 
the coupling of arylhalide 144 and alkyne 121 using the Sonogashira protocol. 
Dihydroisoquinoline 124 was obtained by intramolecular hydroamination of amino 
alkyne 123. Employing Noyori´s protocol, S-configuration at C-1 of the 
benzylisoquinoline was constructed in 93% ee. Finally, the methylation of 
norlaudanosine (146) under the conditions of a reductive amination afforded (–)-(S)-
laudanosine (101). Alternatively, the formation of the berberin bridge using a Pictet-
Spengler reaction afforded (+)-(S)-xylopinine (102). 
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The success of the synthesis of laudanosine (101) and xylopinine (102) motivated us to 
apply this strategy toward the synthesis of benzylisoquinolines with electron-deficient 
A-rings. The first molecular target in this context was 6-trifluoromethyl-
benzylisoquinoline (174). Applying the described method, 6-trifluoromethyl-
benzylisoquinoline (174) was successfully synthesized in 20% yield over 8 steps from 
commercially available 4-bromo-trifluorotoluene (162).  
 
 
F3C
Br
1. I2, Na2IO4
    Ac2O, AcOH, H2SO2
2. iPrMgCl·LiCl
    HCHO
162
F3C
Br
OH
167
F3C
Br
CN3. PBr3
4. NaCN,DMSO
170
5. Cat. Pd(PH3)2Cl2, PPh3, CuI,
    iPr2NH, DMF
    + 121
6. LiAlH4·AlCl3
F3C
OCH3
OCH3
NH2
172
F3C
N
OCH3
OCH3
CH3
7. Cat. Ind2TiMe2
    NaCNBH3, ZnCl2
8. HCHO
    NaBH4
174
69% 49%
89% 64%
 
 
With the experience of the synthesis of 174, the next target was synthesized following a 
similar route. Again, both the Sonogashira reaction and the intramolecular 
hydroamination worked successfully to give the desired products in excellent yields. The 
6,7-difluoro-benzylisoquinoline 182 was obtained in 19% yield from commercially 
available o-bromo-benzoic acid 175 over 8 steps. 
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V EXPERIMENTAL SECTION 
 
5.1. GENERAL REMARKS:  
All reactions were performed under argon in flame dried Duran glassware (e.g. Schlenk 
tubes equipped with Teflon stopcocks). Toluene, diethylether and THF were distilled 
under argon from molten sodium. CH2Cl2 and triethylamine were distilled from calcium 
hydride. Formic acid was distilled from phthalic anhydride. Cp2TiMe2 was synthesized 
according to ref.79 (η6-p-cymene)[(1R,2R)-N-(p-tolylsulfonyl)-1,2-diphenylethylene- 
diamine)]RuCl was synthesized according to ref.41a All other reagents were purchased 
from commercial sources and were used without further purification. For the 
chromatographic purification of products, glass columns of different widths and lengths 
were used depending on the purification problem. Silica gel 60 (0.040-0.063 nm) was 
used as stationary phase and acid washed sea sand was used as filling material. The 
eluent was chosen after preliminary thin layer chromatography experiments. For the 
separation, a light pressure was applied. After isolation of the fractions, the solvents 
were evaporated under reduced pressure, and the resulting purified product was dried 
under high vacuum. Unless otherwise noted, yields refer to isolated yields of pure 
compounds as gauged by thin layer chromatography (TLC) and 1H and 13C NMR 
spectroscopy. All products were characterized by 1H NMR, 13C NMR, IR spectroscopy, 
and mass spectrometry (MS). Additional characterization data were obtained by high-
resolution mass spectrometry (HRMS) and/or CHN elemental analysis. NMR spectra 
were recorded with the following spectrometers: Bruker Avance ARX 250, Bruker 
Avance DRX 300, Bruker AC 300, Bruker Avance DRX 400, Bruker Avance DRX 500. 
All 1H NMR spectra are reported in δ units ppm downfield from tetramethylsilane as 
internal standard or to the singlet of CDCl3 at δ = 7.26 ppm. All 13C NMR spectra are 
reported in δ units ppm relative to the central line of the triplet of CDCl3 at δ = 77.0 
ppm. IR spectra were recorded with a Bruker Vector 22 spectrometer using an 
attenuated total reflection (ATR) method or KBr pellet. Mass spectra were recorded with 
                                                 
79 N. A. Petasis, in: Encyclopedia of Reagents for Organic Synthesis (Ed.: L. A. Paquette), John Wiley & 
Sons, New York, 1995, vol. 1, p. 470–473. 
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a JEOL JMS-700 or a Finnigan TSQ 700 (EI) spectrometer with an ionization potential 
of 70 eV. Elemental analyses were carried out with an Elementar Vario EL machine. ee 
values were determined by HPLC analysis carried out with a Surveyor HPLC System 
Thermo (Chiralcel OD column). Optical rotations were recorded with a Perkin–Elmer 
241 polarimeter at the indicated temperature with the sodium-D-line (λ = 589 nm) in a 
cell of length l = 1 dm. Melting points were determined in an open capillary using a 
mercury thermometer by Tottoli melting point apparatus Büchi 510 and were 
uncorrected. PE: light petroleum ether, b.p. 40–60 °C. MTBE: methyl tert-butyl ether. 
EE: ethyl acetate. 
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5.2. DESCRIPTION OF THE EXPERIMENTS, ANALYTICAL DATA 
 
ENANTIOSELECTIVE SYNTHESIS OF (+)-(S)-LAUDANOSINE AND (−)-(S)-XYLOPININE 
 
H3CO
H3CO
H
N O
O
131  
 [2-(3´,4´-Dimethoxy-phenyl)-ethyl]-carbamic acid t-butyl ester (131): At 0°C, Boc2O 
(8.41 g, 38.5 mmol) and NaOH (2.40 g, 60.0 mmol) were added to a suspension of 
homoveratrylamine (86) (5.44 g, 30.0 mmol) in water (60 mL). After the mixture has 
been stirred at 25°C for 18 h, ethyl acetate (60 mL) was added. The mixture was coolded 
to 0°C and the pH was adjusted to 2-3 with 2 N HCl. After washing with a solution of 
KHSO4 (1 M, 100 mL) and brine (100 mL), the organic layer was dried with Na2SO4 
and the solvent was removed under vacuum. Recrystallization of the residue from 
MTBE/PE gave 131 (7.11 g, 84%) as colourless crystals. Further purification of the 
mother liquor by flash chromatography (SiO2, MTBE/PE = 1:1) provided additional 131 
(1.13 g, 13%). 
M.p.: 57-58°C. 
1H-NMR (400 MHz, CDCl3, TMS): δ = 1.44 (s, 9 H); 2.74 (t, J = 7.0, 2 H); 3.38-3.33 
(m, 2 H); 3.86 (s, 3 H); 3.87 (s, 3 H); 4.58 (br. s, 1 H); 6.72 (s, 1 H); 6.73 (d, J = 8.6 Hz, 
1 H); 6.81 (d, J = 8.0 Hz, 1 H) ppm. 
13C-NMR (100 MHz, DEPT, CDCl3, TMS): δ = 28.4 (CH3), 35.8 (CH2), 41.9 (CH2), 
55.8 (CH3), 55.9 (CH3), 79.2 (C), 111.4 (CH), 112.0 (CH), 120.7 (CH), 131.5 (C), 147.6 
(C), 149.0 (C), 155.9 (C) ppm. 
IR (Golden Gate ATR): υ̃ = 3373, 2988, 2967, 2939, 2874, 2837, 1684, 1592, 1518, 
1464, 1419, 1389, 1365, 1268, 1233, 1170, 1144, 1027, 849, 813, 766, 609 cm-1. 
MS: m/z (%) = 281 (22) [M+], 264 (13), 226 (43), 208 (13), 180 (16), 164 (89), 151 
(100), 149 (9), 121 (9), 107 (12), 94 (14), 91 (8), 79 (8), 77 (9), 66 (7). 
HRMS: calcd. (C15H23NO4) 281.1627, found 281.1623. 
C15H23NO4 (281.3): calcd. C 64.03, H 8.24, N 4.98; found C 63.75, 8.20, N 4.95. 
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H3CO
H3CO
H
N
I
O
O
132  
[2-(2´-Iodo-4´,5´-dimethoxy-phenyl)-ethyl]-carbamic acid t-butyl ester (132): A solution 
of 131 (1.53 g, 5.4  mmol), I2 (0.50 g, 2.2 mmol) and HIO3 (0.19 g, 1.1 mmol) in a 3:1 
mixture of MeOH/H2O (55.0 mL) was heated to 85°C for 48 h. Then, aqueous Na2SO3 
(5%) was added the colour of iodine disappeared. The mixture was extracted with 
CH2Cl2 (3x50 mL). The combined organic layers were dried with Na2SO4 and the 
solvent was removed under vacuum. Recrystallization of residue from MTBE/PE gave 
132 (1.20 g, 55%) as pale-yellowish crystals and further purification by flash 
chromatography (SiO2, MTBE/PE = 1:1) of the mother liquor provided additional 132 
(0.52 g, 24%).  
M.p.: 83-84°C. 
1H-NMR (400 MHz, CDCl3, TMS): δ = 1.44 (s, 9 H); 2.87 (t, J = 7.1 Hz, 2 H); 3.36-
3.31 (m, 2 H); 3.85 (s, 6 H); 4.62 (br. s, 1 H); 6.74 (s, 1 H); 7.21 (s, 1 H) ppm.  
13C-NMR (100 MHz, DEPT, CDCl3): δ = 28.5 (CH3), 40.4 (CH2), 40.7 (CH2), 56.0 
(CH3), 56.2 (CH3), 79.3 (C), 88.1 (C), 112.8 (CH), 121.8 (CH), 134.1 (C), 148.3 (C), 
155.9 (C) ppm. 
IR (Golden Gate ATR): υ̃ = 3335, 3003, 2970, 2932, 2871, 2843, 1686, 1541, 1509, 
1498, 1458, 1442, 1379, 1367, 1302, 1291, 1253, 1221, 1164, 1030, 861 cm-1. 
MS: m/z  (%) =  407 (40), 351 (49), 333 (13), 290 (100), 277 (74), 263 (10), 233 (10), 
224 (28), 207 (25), 180 (91), 164 (28), 151 (37), 135 (12), 121 (11), 107 (17), 91 (9), 79 
(10), 77 (13). 
HRMS: calcd. (C15H23NO4I) 407.0594, found 407.0584. 
 
H3CO
H3CO I
135  
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4-Iodo-1,2-dimethoxy-benzene (135): A solution of veratrol (134) (13.82 g, 100 mmol), 
I2 (10.12 g, 40.0 mmol), and HIO3 (3.52 g, 20.0 mmol) in a 3:1 mixture of MeOH/H2O 
(1000 mL) was heated to 85°C for 48 h. Then, aqueous Na2SO3 (5%) was added until 
the iodine color disappeared. The mixture was extracted with CH2Cl2 (3×150 mL) and 
the combined organic layers were dried with Na2SO4. After concentration under vacuum 
and purification by Kugelrohr distillation, 135 (24.32 g, 92.1 mmol, 92%) was isolated 
as a yellow oil.  
1H NMR (300 MHz, CDCl3): δ = 3.84 (s, 3 H), 3.85 (s, 3 H), 6.61 (d, J = 8.5 Hz, 1 H), 
7.11 (d, J = 1.8 Hz, 1 H), 7.22 (dd, J = 1.8, 8.5 Hz, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 55.9 (CH3), 56.1 (CH3), 82.3 (C), 113.2 (CH), 
120.4 (CH), 129.8 (CH), 149.2 (C), 149.9 (C) ppm.  
IR: ν = 2955, 2930, 2836, 1583, 1503, 1460, 1439, 1393, 1321, 1250, 1229, 1177, 1157, 
1022, 838, 797, 762, 614 cm–1.  
MS: m/z (%) = 264 (83) [M+], 249 (26), 221 (31), 218 (18), 203 (17), 122 (19), 94 (100), 
79 (33), 77 (23), 66 (24).  
HRMS: calcd. (C8H9IO2) 263.9647; found 263.9647. 
 
H3CO
H3CO
Si(CH3)3
140  
(3,4-Dimethoxy-phenylethynyl)-trimethyl-silane (140): Pd(PPh3)2Cl2 (282 mg, 0.40 
mmol, 2 mol-%), CuI (160 mg, 0.84 mmol, 4 mol-%), PPh3 (208 mg, 0.80 mmol, 4 mol-
%), and iPr2NH (60 mL) were placed in a round-bottomed flask. After addition of 4-
iodoveratrol (135) (5.28 g, 20.0 mmol), the mixture was stirred at 25°C for 30 min, and 
trimethylsilylacetylene (1.96 g, 20.0 mmol) was then added. After this mixture has been 
stirred at 25°C for an additional 16 h, a saturated NH4Cl solution was added. The 
mixture was extracted with CH2Cl2 (3×50 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum. After purification by flash 
chromatography (SiO2, PE/MTBE, 3:1), 140 (4.31 g, 18.4 mmol, 92%) was isolated as a 
yellow oil.  
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1H NMR (400 MHz, CDCl3): δ = 0.24 (s, 9 H), 3.87 (s, 3 H), 3.87 (s, 3 H), 6.76 (d, J = 
8.3 Hz, 1 H), 6.96 (d, J = 1.8 Hz, 1 H), 7.07 (dd, J = 1.9, 8.3 Hz, 1 H) ppm.  
13C NMR (100 MHz, DEPT, CDCl3): δ = 0.0 (CH3), 55.8 (CH3), 55.9 (CH3), 92.3 (C), 
105.2 (C), 110.8 (CH), 114.6 (CH), 115.3 (C), 125.4 (CH), 148.5 (C), 149.7 (C) ppm.  
IR: ν = 3001, 2958, 2835, 2156, 1599, 1577, 1514, 1464, 1442, 1409, 1322, 1266, 1243, 
1197, 1163, 1137, 1027, 951, 855, 765 cm–1.  
MS: m/z (%) = 234 (58) [M+], 219 (100), 203 (11), 162 (14), 151 (13), 138 (10), 113 
(10), 109 (4), 95 (4), 77 (8).  
HRMS: calcd. (C13H18O2Si) 234.1076; found 234.1058. 
C13H18O2Si (234.4): calcd. C 66.62, H 7.74; found C 66.57, H 7.82. 
H3CO
H3CO
121  
4-Ethynyl-1,2-dimethoxy-benzene (121): Anhydrous K2CO3 (138 mg, 1.00 mmol) was 
added to a solution of 140 (2.41 g, 10.3 mmol) in MeOH (25 mL). After this mixture had 
been stirred at 25°C for 4 h, the solvent was evaporated under vacuum. A saturated 
aqueous NaHCO3 was added to the residue and the mixture was extracted with CH2Cl2 
(3×50 mL). The combined organic layers were dried with MgSO4 and concentrated 
under vacuum. After purification by flash chromatography (SiO2, PE/MTBE, 1:1), 121 
(1.37 g, 8.45 mmol, 82%) was isolated as a white crystalline solid.  
M.p.: 70-71°C.  
1H NMR (300 MHz, CDCl3): δ = 3.00 (s, 1 H), 3.87 (s, 3 H), 3.88 (s, 3 H), 6.79 (d, J = 
8.3 Hz, 1 H), 6.98 (d, J = 1.8 Hz, 1 H), 7.10 (dd, J = 1.8, 8.3 Hz, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 55.9 (CH3), 75.6 (CH), 83.7 (C), 110.9 (CH), 
114.2 (C), 114.7 (CH), 125.4 (CH), 148.6 (C), 149.9 (C) ppm.  
IR: ν = 3428, 3259, 3250, 3007, 2971, 2939, 2843, 1597, 1579, 1511, 1452, 1446, 1408, 
1323, 1263, 1240, 1152, 1138, 1035, 1026, 860, 821, 810, 730, 621 cm–1.  
MS: m/z (%) = 162 (100) [M+], 147 (21), 119 (10), 91 (14), 76 (8), 65 (6).  
HRMS: calcd. (C10H10O2) 162.0681; found 162.0659.  
C10H10O2 (162.2): calcd. C 74.06, H 6.21; found C 73.66, H 6.14. 
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H3CO
H3CO
H
N
Si(CH3)3
O
O
136  
[2-(4´,5´-Dimethoxy-2´´-trimethylsilanylethynyl-phenyl)-ethyl]-carbamic acid t-butyl 
ester (136): Pd(PPh3)2Cl2 (141 mg, 0.2 mmol, 2 mol-%), CuI (76 mg, 0.4 mmol, 4 mol-
%), PPh3 (105 mg, 0.4 mmol, 4 mol-%) and  i-Pr2NH (60.0 mL) were placed in a round-
bottomed flask. After addition of 132 (4.07 g, 10.0 mmol), the mixture was stirred at 
25°C for 30 min, and trimetylsilylacetylene (0.98 g, 10.0 mmol) was added. After this 
mixture had been stirred at 25°C for additional 16 h, a saturated NH4Cl solution was 
added. The mixture was extracted with CH2Cl2 (3x 50 mL). The combined organic 
layers were dried with MgSO4 and concentrated under vacuum. After purification by 
flash chromatography   (SiO2, MTBE:PE, 1:1), 136 (2.64 g, 70%) was isolated  as a 
colourless oil. 
1H-NMR (400 MHz, CDCl3): δ = 0.24 (s, 9 H) 1.41 (s, 9 H); 2.91 (t, J = 6.8 Hz, 2 H); 
3.41-3.37 (m, 2 H); 3.84 (s, 3 H); 3.86 (s, 3 H); 4.64 (br. s, 1 H); 6.67 (s, 1 H); 6.92 (s, 1 
H) ppm.  
13C-NMR (100 MHz, DEPT, CDCl3): δ = 0.0 (CH3), 28.4 (CH3), 34.3 (CH2), 41.1 
(CH2), 55.8 (CH3), 55.9 (CH3), 79.0 (C), 96.6 (C), 103.9 (C), 112.2 (CH), 114.4 (C), 
114.7 (CH), 135.1 (C), 147.1 (C), 149.6 (C), 155.8 (C) ppm. 
IR (film): υ̃ =  3386, 2961, 2147, 1713, 1604, 1511, 1465, 1392, 1365, 1343, 1250, 
1227, 1200, 1172, 1112, 1005, 861, 760 cm-1. 
MS: m/z  (%) =  377 (74) [M+], 321 (42), 288 (4), 276 (19), 262 (19), 248 (34), 247 
(100), 245 (27), 233 (14), 217 (9), 189 (6), 188 (20), 162 (13), 131 (4), 113 (9). 
HRMS: calcd. (C20H31NO4Si) 377,2022 found 377.2007. 
C20H31NO4Si (377.5): calcd. C 63.62, H 8.28, N 3.71; found C 63.70, H 8.50, N 3.74. 
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H3CO
H3CO
H
N
OCH3
OCH3
O
O
139  
{2-[2-(3,4-Dimethoxy-phenylethynyl)-4,5-dimethoxy-phenyl]-ethyl}-carbamic acid t-
butyl ester (139): Pd(PPh3)2Cl2 (70 mg, 0.1 mmol, 2 mol-%), CuI (38 mg, 0.2 mmol, 4 
mol-%), PPh3 (52 mg, 0.2 mmol, 4 mol-%) and i-Pr2NH (15 mL) were placed in a round-
bottomed flask. After addition of aryl iodide 132 (2.04 g, 5.0 mmol), the mixture was 
stirred at 25°C for 30 mi, and alkyne 121 (0.81 g, 5.0 mmol) was then added. After this 
mixture had been stirred at 25°C for additional 16 h, a saturated NH4Cl solution was 
added. The mixture was extracted with CH2Cl2 (3x50). The combined organic layers 
were dried with MgSO4 and concentrated under vacuum. After purification by flash 
chromatography (SiO2, MTBE:PE, 1:1), 139 (2.11 g, 4.8 mmol, 96%) was isolated as a 
pale-yellowish solid. 
M.p.: 113-114°C. 
1H-NMR (400 MHz, CDCl3): δ = 1.40 (s, 9 H); 2.98 (t, J = 6.9 Hz, 2 H); 3.43-3.45 (m, 2 
H); 3.87 (s, 3 H); 3.88 (s, 3 H); 3.89 (s, 3 H); 3.91 (s, 3 H); 6.71 (s, 1 H); 6.82 (d, J = 8.3 
Hz, 1 H); 6.99 (s, 1 H); 7.02 (d, J =  1.7 Hz, 1 H); 7.11 (dd, J = 1.9, 8.3 Hz, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 28.38 (CH3), 34.65 (CH2), 40.1 (CH2), 55.90 
(CH3), 55.95 (CH3), 55.98 (CH3), 79.3 (C), 86.44 (C), 91.79 (C), 111.06 (CH), 112.32 
(CH), 114.11 (CH), 114.58 (CH), 115.63 (C), 124.71 (CH), 134.19 (C), 147.27 (C), 
148.70 (C), 149.25 (C), 149.42 (C), 155.87 (C) ppm. 
IR (KBr): υ̃ = 3374, 2964, 2935, 2857, 1690, 1598, 1575, 1517, 1465, 1413, 1392, 1365, 
1346, 1323, 1244, 1171, 1136, 1092, 1027, 855, 816, 807 cm-1. 
MS : m/z  (%) =  441 (20) [M+], 407 (8), 385 (4); 367 (3), 351 (14), 340 (5), 324 (14), 
322 (23), 311 (20) 299 (14), 289 (18), 281 (28), 276 (33), 262 (44), 251 (10), 225 (33), 
208 (22), 183 (27), 180 (15), 165 (20), 164 (81), 151 (100), 131 (4), 113 (6), 107 (7), 91 
(5), 77 (6). 
HRMS: calcd. (C25H31NO6) 441.2151; found 441.2178. 
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C25H31NO6 (441.5): calcd. C 68.01, H 7.08, N 3.17; found C 67.70, H 6.96, N 3.25. 
 
H3CO
H3CO
H
N O
O
141  
[2-(2-Ethynyl-4´, 5´-dimethoxy-phenyl)-ethyl]-carbamic acid t-butyl ester (141): 
Anhydrous K2CO3 (97 mg, 0.7 mmol) was added to a solution of 136 (2.06 g, 5.4 mmol) 
in MeOH (13.5 mL). After this mixture has been stirred at 25°C for 3 h, the solvent was 
evaporated under vacuum. A saturated aqueous NaHCO3 was added to the residue and 
the mixture was extracted with CH2Cl2 (3x50 mL). The combined organic layers were 
dried with MgSO4 and concentrated under vacuum. After purification by flash 
chromatography (SiO2, MTBE:PE, 1:1) 141 (1.46 g, 4.8, 88%) was isolated as a 
colourless solid. 
M.p.: 105-107°C. 
1H-NMR (400 MHz, CDCl3): δ = 1.41 (s, 9 H); 2.95 (t, J = 6.8 Hz, 2 H); 3.17 (s, 1 H); 
3.34-3.41 (m, 2 H); 3.84 (s, 3 H); 3.86 (s, 3 H); 6.68 (s, 1 H); 6.94 (s, 1 H) ppm. 
13C-NMR (100 MHz, DEPT, CDCl3): δ = 28.4 (CH3), 34.3 (CH2), 41.0 (CH2), 55.9 
(CH3), 79.0 (C), 79.4 (CH), 82.3 (C), 112.2 (CH), 113.4 (C), 115.2 (CH), 131.0 (C), 
135.1 (C), 147.2 (C), 149.7 (C), 155.8 (C) ppm. 
IR (KBr): υ̃ =  3417, 3237, 3006, 2976, 2935, 2873, 2097, 1702, 1604, 1515, 1440, 
1390, 1366, 1356, 1330, 1285, 1266, 1229, 1168, 1102, 1018, 1007, 855 cm-1. 
MS: m/z  (%) =  305 (65) {M+], 249 (62), 232 (31), 204 (10), 188 (64), 175 (100), 173 
(4), 161 (11), 145 (9), 131 (10), 115 (6), 113 (9), 102 (6), 89 (4), 77 (3), 57 (34). 
HRMS: calcd. (C17H23NO4) 305.1627; found 305.1619. 
C17H23NO4 (305.4): calcd. C 66.86, H 7.59, N 4.59; found C 66.59, H 7.55, N 4.72.  
 
H3CO
H3CO
NH2
142  
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2-(2-ethynyl-4,5-dimethoxyphenyl)ethanamine (142): At 0°C, F3CCOOH (1,5 mL, 1.5 
mmol) was added to a solution of 141 (1.14 g, 3.0 mmol) in CH2Cl2 (18 mL). After this 
mixture has been stirred at 25°C for 18 h, the solution was neutralized by saturated 
NaHCO3 solution and the mixture was extracted with CH2Cl2 (3x 50 mL). The 
combined organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, EtOAc + 3% NH3) gave 142 (529 mg, 2.6 
mmol, 86%) as a very hygroscopic pale yellowish solid.  
1H NMR (300 MHz, CDCl3): δ = 2.88 (t, J = 6.2 Hz, 2 H), 2.95-2.95 (m, 2 H), 3.17 (s, 1 
H), 3.84 (s, 3 H), 3.87 (s, 3 H), 6.69 (s, 1 H), 6.96 (s, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 38.3 (CH2), 43.0 (CH2), 55.9 (CH3), 56.0 (CH3), 
79.2 (CH), 82.5 (C), 112.2 (CH), 113.5 (C), 115.3 (CH), 136.0 (C), 147.0 (C), 149.7 (C) 
ppm. 
IR (film): υ̃ = 3280, 3001, 2936, 2850, 2096, 1604, 1573, 1512, 1464, 1396, 1344, 1261, 
1222, 1193, 1098, 1030, 995, 861, 810, 747, 657  cm-1 
MS: m/z (%) = 205 (16) [M+], 176 (100), 162 (10), 151 (16), 131 (5), 113 (10). 
HRMS: calcd. (C12H15NO2) 205.1103; found 250.1098. 
 
H3CO
H3CO
H
N CF3
O
143  
N-[2-(3,4-Dimethoxy-phenyl)-ethyl]-2,2,2-trifluoro-acetamide (143): At 25°C, ethyl 
trifluoroacetate (10.58 g, 74.5 mmol) was added dropwise to a solution of 
homoveratrylamine (86) (7, 11.75 g, 65.0 mmol) in THF (325 mL). The mixture was 
stirred at 25°C for 2 h. Evaporation of the solvent under vacuum gave 143 (17.98 g, 64.9 
mmol, 99%) as a white solid. For the subsequent iodination, the product was used 
without further purification. 
M.p.: 81–82°C.  
1H NMR (500 MHz, CDCl3): δ = 2.82 (t, J = 7.0 Hz, 2 H), 3.57–3.61 (m, 2 H), 3.86 (s, 6 
H), 6.36 (br. s, 1 H), 6.68 (d, J = 1.4 Hz, 1 H), 6.72 (dd, J = 1.7, 8.4 Hz, 1 H), 6.82 (d, J 
= 8.0 Hz, 1 H) ppm.  
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13C NMR (125 MHz, DEPT, CDCl3): δ = 34.5 (CH2), 41.1 (CH2), 55.8 (CH3), 55.9 
(CH3), 111.5 (CH), 111.7 (CH), 115.8 (q, J = 288 Hz, CF3), 120.6 (CH), 130.0 (C), 
148.2 (C), 149.2 (C), 157.1 (q, J = 37 Hz, C) ppm.  
IR: ν = 3426, 3319, 3116, 3009, 2966, 2943, 2840, 1700, 1591, 1566, 1515, 1469, 1460, 
1454, 1444, 1264, 1250, 1238, 1215, 1201, 1181, 1160, 1137, 1029, 805 cm–1. 
MS: m/z (%) = 277 (29) [M+], 164 (42), 151 (100), 113 (7), 107 (6), 91 (3), 78 (3).  
HRMS: calcd. (C12H14F3NO3) 277.0926; found 277.0944.  
C12H14F3NO3 (277.2): calcd. C 51.99, H 5.09, N 5.05; found C 51.77, H 4.96, N 5.05.  
 
H3CO
H3CO
H
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O
I
144  
2,2,2-Trifluoro-N-[2-(2-iodo-4,5-dimethoxy-phenyl)-ethyl]-acetamide (144): A solution 
of 143 (17.98 g, 64.9 mmol), I2 (6.57 g, 25.9 mmol), and HIO3 (2.29 g, 13.0 mmol) in a 
3:1 mixture of MeOH/H2O (650 mL) was heated to 85°C for 48 h. After concentration 
under vacuum, the residue was dissolved in CH2Cl2 (150 mL). The solution was washed 
with aqueous Na2SO3 (5%, 50 mL), H2O (100 mL) and brine (100 mL). The combined 
organic layers were dried with MgSO4. After concentration under vacuum and 
purification by flash chromatography (SiO2, PE/EtOAc, 4:1), 144 (24.42 g, 60.6 mmol, 
93%) was isolated as a white solid.  
M.p.: 122–123°C.  
1H NMR (250 MHz, CDCl3): δ = 2.97 (t, J = 7.0 Hz, 2 H), 3.55–3.64 (m, 2 H), 3.84 (s, 3 
H), 3.85 (s, 3 H), 6.39 (br. s, 1 H), 6.69 (s, 1 H), 7.22 (s, 1 H) ppm.  
13C NMR (125 MHz, DEPT, CDCl3): δ = 39.0 (CH2), 40.0 (CH2), 55.9 (CH3), 56.2 
(CH3), 87.9 (C), 112.6 (CH), 115.7 (q, J = 288 Hz, CF3), 121.9 (CH), 132.6 (C), 148.6 
(C), 149.6 (C), 157.1 (q, J = 37 Hz, C) ppm.  
IR: ν = 3434, 2941, 2844, 1708, 1636, 1627, 1599, 1561, 1508, 1465, 1457, 1441, 1380, 
1256, 1218, 1181, 1163, 1028, 858, 786, 727 cm–1.  
MS: m/z (%) = 403 (62) [M+], 290 (50), 277 (100), 179 (3), 164 (5), 151 (8), 113 (6), 91 
(2), 77 (4).  
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HRMS: calcd. (C12H13F3INO3) 402.9892; found 402.9866.  
C12H13F3INO3 (403.1): calcd. C 35.75, H 3.25, N 3.47; found C 35.97, H 3.34, N 3.51.  
 
H3CO
H3CO
H
N CF3
O
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145  
N - {2 - [2 - (3,4 - Dimethoxy-phenylethynyl) - 4,5 – dimethoxy - phenyl] - ethyl} - 
2,2,2 – trifluoro - acetamide (145): Pd(PPh3)2Cl2 (186 mg, 0.26 mmol, 4 mol-%), CuI 
(101 mg, 0.53 mmol, 8 mol-%), PPh3 (138 mg, 0.51 mmol, 8 mol-%), and iPr2NH (19 
mL) were placed in a round-bottomed flask. After addition of aryl iodide 144 (2.66 g, 
6.60 mmol), the mixture was stirred at 25°C for 30 min, and alkyne 121 (1.07 g, 6.60 
mmol) was then added. After this mixture had been stirred at 25°C for an additional 16 
h, saturated NH4Cl solution was added. The mixture was extracted with CH2Cl2 (3×50 
mL). The combined organic layers were dried with MgSO4 and concentrated under 
vacuum. After purification by flash chromatography (SiO2, PE/EtOAc, 1:1), 145 (2.41 g, 
5.51 mmol, 84%) was isolated as a yellow crystalline solid.  
M.p.: 164–165°C.  
1H NMR (250 MHz, CDCl3): δ = 3.10 (t, J = 6.6 Hz, 2 H), 3.66–3.74 (m, 2 H), 3.88 (s, 3 
H), 3.89 (s, 3 H), 3.91 (s, 3 H), 3.91 (s, 3 H), 6.48 (br. s, 1 H), 6.68 (s, 1 H), 6.85 (d, J = 
8.3 Hz, 1 H), 7.02 (s, 1 H), 7.04 (d, J = 1.7 Hz, 1 H), 7.11 (dd, J = 1.8, 8.2 Hz, 1 H) 
ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 33.2 (CH2), 40.9 (CH2), 55.9 (CH3), 56.0 (CH3), 
85.9 (C), 92.3 (C), 111.1 (CH), 112.1 (CH), 114.2 (CH), 114.8 (CH), 115.1 (C), 115.2 
(C), 115.8 (q, J = 287 Hz, CF3), 124.7 (CH), 132.7 (C), 147.8 (C), 148.8 (C), 149.6 (C), 
149.7 (C), 157.2 (q, J = 37 Hz, C) ppm.  
IR: ν = 3331, 3008, 2934, 2836, 1704, 1603, 1576, 1518, 1467, 1452, 1352, 1323, 1245, 
1227, 1215, 1179, 1157, 1137, 1092, 1023, 1001, 809 cm–1.  
MS: m/z (%) = 437 (100) [M+], 369 (3), 324 (6), 311 (54), 281 (2), 267 (4), 253 (4), 213 
(4), 201 (5), 161 (10), 150 (11), 113 (8).  
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HRMS: calcd. (C22H22NO5F3) 437.1450; found 437.1445. 
C22H22NO5F3 (437.4): calcd. C 60.41, H 5.07, N 3.20; found C 60.14, H 5.15, N 3.24. 
 
H3CO
H3CO
NH2
OCH3
OCH3
123  
2-[2-(3,4-Dimethoxy-phenylethynyl)-4,5-dimethoxy-phenyl]-ethylamine (123): 
Aqueous KOH (5 M, 11.0 mL, 55.0 mmol) was added to a solution of 146 (2.37 g, 5.42 
mmol) in MeOH (55 mL) at 0°C. The cooling bath was removed and the mixture was 
stirred at 25°C for 20 h. Then, the MeOH was removed under vacuum and the residue 
was diluted with H2O (50 mL). After extraction with CH2Cl2 (4×50 mL), the combined 
organic layers were dried with MgSO4 and concentrated under vacuum. Purification by 
flash chromatography (SiO2, EtOAc/MeOH, 1:1 + 3% NH3) gave 123 (1.66 g, 4.86 
mmol, 90%) as a very hygroscopic pale brown solid. Amino alkyne 123 was stored as a 
solution in CH2Cl2 (100 mg/mL) at 4°C.  
1H NMR (250 MHz, CDCl3): δ = 1.39 (s, 2 H), 2.90–2.97 (m, 2 H), 3.01–3.08 (m, 2 H), 
3.88 (s, 3 H), 3.89 (s, 6 H), 3.90 (s, 3 H), 6.73 (s, 1 H), 6.83 (d, J = 8.4 Hz, 1 H), 7.01 (s, 
2 H), 7.11 (dd, J = 1.9, 8.3 Hz, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 37.2 (CH2), 42.2 (CH2), 55.7 (CH3), 55.8 (CH3), 
55.8 (CH3), 86.4 (C), 91.6 (C), 111.0 (CH), 112.4 (CH), 114.0 (CH), 114.6 (CH), 114.8 
(C), 115.5 (C), 124.6 (CH), 134.1 (C), 147.1 (C), 148.6 (C), 149.1 (C), 149.3 (C) ppm.  
IR: ν = 3360, 3003, 2939, 2830, 1599, 1576, 1517, 1465, 1348, 1322, 1244, 1224, 1181, 
1156, 1089, 1022, 996, 854, 813, 805, 764 cm–1.  
MS: m/z (%) = 341 (90) [M+], 326 (19), 312 (100), 297 (22), 281 (6), 267 (7), 253 (11), 
225 (4), 216 (5), 204 (15), 190 (20) 161 (11), 151 (12), 113 (8).  
HRMS: calcd. (C20H23NO4) 341.1627; found 341.1630. 
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1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-3,4-dihydro-isoquinoline (124): A solution of 
123 in CH2Cl2 (6.83 mL, c = 100 mg/mL, 2.00 mmol) was transferred to a Schlenk tube 
and the solvent was removed under vacuum. Then, toluene (0.5 mL) and a solution of 
Cp2TiMe2 (0.54 mL, c = 0.37 mol/L in toluene, 0.20 mmol, 10 mol-%) were added. The 
reaction mixture was heated to 110°C for 16 h. After the obtained brown liquid had been 
allowed to reach room temperature, the solvent was removed under vacuum. Purification 
of the residue by flash chromatography (SiO2, EtOAc + 4% NEt3) provided 124 (669 
mg, 1.96 mmol, 98%) as a yellow solid.  
1H NMR (250 MHz, CDCl3): δ = 2.63 (t, J = 7.7 Hz, 2 H), 3.71 (t, J = 7.7 Hz, 2 H), 3.74 
(s, 3 H), 3.81 (s, 3 H), 3.82 (s, 3 H), 3.87 (s, 3 H), 3.97 (s, 2 H), 6.64 (s, 1 H), 6.74–6.86 
(m, 3 H), 6.98 (s, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 25.3 (CH2), 40.3 (CH2), 43.7 (CH2), 55.6 (CH3), 
55.8 (CH3), 55.9 (CH3), 56.0 (CH3), 110.5 (CH), 110.7 (CH), 111.4 (CH), 111.7 (CH), 
119.6 (C), 120.7 (CH), 128.5 (C), 132.7 (C), 147.7 (C), 148.1 (C), 149.3 (C), 153.0 (C), 
169.6 (C) ppm.  
IR: ν = 2992, 2934, 2832, 2803, 1609, 1589, 1515, 1465, 1449, 1416, 1374, 1326, 1301, 
1262, 1233, 1173, 1154, 1138, 1154, 1138, 1111, 1026, 983, 950, 862, 821, 805, 787, 
766, 698, 546 cm–1.  
MS: m/z (%) = 341 (3) [M+], 340 (4), 326 (4), 194 (7), 193 (79), 192 (100), 177 (14), 
176 (33), 151 (19), 148 (15), 147 (10), 131 (8), 118 (6), 106 (4).  
HRMS: calcd. (C20H23NO4) 341.1627; found 341.1592. 
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(–)-(S)-Norlaudanosine (146): A 5:2 mixture of HCOOH and NEt3 (1.5 mL) was added 
to a suspension of imine 124 (1.02 g, 3.00 mmol) and (η6-p-cymene)[(1R,2R)-N-(p-
tolylsulfonyl)-1,2-diphenylethylenediamine)]RuCl (19 mg, 0.03 mmol) in DMF (6.0 
mL). After the mixture had been stirred at 25°C for 7 h, a saturated aqueous Na2CO3 
solution (30 mL) was added. The resulting mixture was extracted with CH2Cl2 (3×30 
mL) and the combined organic layers were dried with MgSO4. After concentration under 
vacuum and purification by flash chromatography (SiO2, EtOAc/MeOH, 4:1 + 1% NH3), 
146 (951 mg, 2.77 mmol, 92%, 93% ee, HPLC: hexane/2-propanol/diethylamine, 
55:45:0.1, 0.5 mL/min) was isolated as a yellow oil.  
25[ D]α   = –23.6 (c = 0.85, CHCl3).   
1H NMR (300 MHz, CDCl3): δ = 2.65–2.76 (m, 2 H), 2.82–2.95 (m, 2 H), 3.14–3.24 (m, 
2 H), 3.83 (s, 3 H), 3.86 (s, 3 H), 3.86 (s, 3 H), 3.87 (s, 3 H), 4.13 (dd, J = 4.4, 9.2 Hz, 1 
H), 6.59 (s, 1 H), 6.66 (s, 1 H), 6.75–6.84 (m, 3 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 29.5 (CH2), 41.0 (CH2), 42.2 (CH2), 55.9 (CH3), 
55.9 (CH3), 56.0 (CH3), 56.8 (CH3), 78.7 (CH), 101.7 (C), 109.4 (CH), 111.3 (CH), 
111.8 (CH), 112.4 (CH), 121.4 (CH), 127.4 (C) 131.4 (C), 147.0 (C), 147.5 (C), 147.7 
(C), 148.6 (C) ppm.  
IR: ν = 3330, 2997, 2934, 2833, 1509, 1585, 1515, 1464, 1412, 1379, 1320, 1266, 1157, 
1140, 112, 1028, 945, 859, 811, 729 cm–1.  
MS: m/z (%) = 343 (2) [M+], 342 (9), 341 (24), 326 (15), 266 (3), 206 (17), 193 (74), 
192 (100), 177 (12), 176 (27), 162 (5), 151 (16), 131 (6).  
HRMS: calcd. (C20H25NO4) 343.1784; found 343.1717. 
 
One-pot procedure of Cp2TiMe2-catalyzed hydroamination/asymmetric Ru-catalyzed 
transfer hydrogenation reduction to synthesize norlaudanosine (146): A solution of 123 
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in dichloromethane (1.71 mL, c = 100 mg/mL, 0.50 mmol) was transferred to a Schlenk 
tube and the solvent was removed under vacuum. Then, toluene (0.5 mL) and a solution 
of Cp2TiMe2 (0.14 mL, c = 0.37 mol/L in toluene, 0.05 mmol, 10 mol-%) were added. 
The reaction mixture was heated at 110°C for 16 h. The hydroamination product was 
then allowed to reach room temperature. In the other flash, [RuCl2(p-cymene)]2 (1.5 mg, 
0.0025 mmol) and TsDPEN (25.0 mg, 0.005 mmol) were dissolved in 1 mL of water and 
stirred at 40°C for 1 h. The Ru-TsDPEN solution and HCOONa (170 mg, 2.5 mmol) 
were then added the resulted hydroamination mixture. Following degassing three times, 
the solution was stirred at 40°C for 24 h. A saturated aqueous Na2CO3 solution (30 mL) 
was added to the solution. The resulting mixture was extracted with diethylether (3×30 
mL) and the combined organic layers were dried with MgSO4. After concentration under 
vacuum and purification by flash chromatography (SiO2, EtOAc/MeOH, 4:1 + 1% NH3), 
146 (160 mg, 0.47 mmol, 93%, 60% ee) was isolated as a yellow oil. The ee value was 
determined by HPLC with ODH column, hexane/2-propanol, 60:40, 0.5 mL/min, time 
retention 23.9 min (S) and 31.8 min (R). 
 
H3CO
H3CO
OCH3
OCH3
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101  
(+)-(S)-Laudanosine (101): Aqueous CH2O (2.0 mL, c = 37%) was added to a solution 
of 146 (330 mg, 0.96 mmol) in MeOH (6.0 mL). After this mixture had been stirred at 
25°C for 3 h, NaBH4 (400 mg, 10.57 mmol) was slowly added. Subsequently, the 
reaction mixture was stirred at 25°C for an additional 16 h. Then, saturated aqueous 
NH4Cl (25 mL) was added and the mixture was extracted with CH2Cl2 (3×30 mL). The 
combined organic layers were dried with MgSO4 and the solvent was evaporated under 
vacuum. After purification by flash chromatography (SiO2, MTBE/MeOH/NEt3, 95:3:3), 
(+)-(S)-laudanosine (101) (340 mg, 0.95 mmol, 99%) was isolated as a cream-colored 
solid.  
M.p.: 88–89°C. 
EXPERIMENT SECTION 
 74
25[ D]α  = +87 (c = 0.70, EtOH).  
1H NMR (300 MHz, CDCl3): δ = 2.53 (s, 3 H), 2.56–2.60 (m, 1 H), 2.71–2.85 (m, 3 H), 
3.10–3.18 (m, 1 H), 3.56 (s, 3 H), 3.66–3.70 (m, 1 H), 3.77 (s, 3 H), 3.82 (s, 3 H), 3.83 
(s, 3 H), 6.04 (s, 1 H), 6.54 (s, 1 H), 6.58–6.63 (m, 2 H), 6.75 (d, J = 8.1 Hz, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 25.5 (CH2), 40.8 (CH2), 42.6 (CH3), 47.0 (CH2), 
55.5 (CH3), 55.7 (CH3), 55.7 (CH3), 55.9 (CH3), 64.8 (CH), 111.0 (CH), 111.1 (CH), 
111.2 (CH), 113.0 (CH), 121.8 (CH), 126.0 (C), 129.2 (C), 132.5 (C), 146.3 (C), 147.2 
(C), 147.3 (C), 148.5 (C) ppm.  
IR: ν = 2993, 2915, 2789, 1607, 1516, 1466, 1451, 1374, 1334, 1281, 1265, 1227, 1204, 
1155, 1142, 1104, 1029, 1018, 861, 818 cm–1.  
MS: m/z (%) = 358 (80) [M+ + H], 342 (3), 307 (22), 289 (11), 222 (3), 206 (100), 204 
(18), 190 (10).  
HRMS: calcd. (C21H28NO4) 358.2018; found 358.2000.  
C21H27NO4 (357.4): calcd. C 70.56, H 7.61, N 3.92; found C 70.28, H 7.61, N 3.98. 
 
H3CO
H3CO
OCH3
N
102 OCH3  
(–)-(S)-Xylopinine (102): A mixture of aqueous CH2O (0.8 mL, c = 37 %), HCOOH 
(1.2 mL), and 146 (52 mg, 0.15 mmol) was heated to 90°C for 2 h. After the resulting 
mixture had cooled to 25°C, saturated aqueous NaHCO3 was added until pH 7 was 
reached. The mixture was then extracted with dichloromethane (3×15 mL). The 
combined organic layers were dried with MgSO4 and the solvent was evaporated under 
vacuum. After purification by flash chromatography (SiO2, EtOAc/NEt3, 99:1), (–)-(S)-
xylopinine (102) (44 mg, 0.12 mmol, 82%) was isolated as a cream-colored solid.  
M.p.: 178–180°C.  
25[ D]α = –262 (c = 0.10, CHCl3).  
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1H NMR (300 MHz, CDCl3): δ = 2.57–2.69 (m, 2 H), 2.84 (dd, J = 11.5, 15.1 Hz, 1 H), 
3.09–3.16 (m, 2 H), 3.24 (dd, J = 3.7, 15.8 Hz, 1 H), 3.59 (dd, J = 3.7, 11.4 Hz, 1 H), 
3.67 (d, J = 14.3 Hz, 1 H), 3.85 (s, 3 H), 3.86 (s, 3 H), 3.87 (s, 3 H), 3.89 (s, 3 H), 3.95 
(d, J = 14.7 Hz, 1 H), 6.58 (s, 1 H), 6.62 (s, 1 H), 6.66 (s, 1 H), 6.74 (s, 1 H) ppm.  
13C NMR (75 MHz, DEPT, CDCl3): δ = 29.1 (CH2), 36.4 (CH2), 51.4 (CH2), 55.8 (CH3), 
55.9 (CH3), 56.0 (CH3), 56.1 (CH3), 58.3 (CH2), 59.6 (CH), 108.6 (CH), 109.1 (CH), 
111.4 (CH), 111.5 (CH), 126.3 (C), 126.4 (C), 126.8 (C), 129.8 (C), 147.4 (C), 147.5 
(C), 147.5 (C), 147.7 (C) ppm.  
IR: ν = 3435, 2931, 2833, 1612, 1518, 1464, 1384, 1350, 1329, 1260, 1241, 1205, 1144, 
1102, 1005, 856, 787, 769 cm–1.  
MS: m/z (%) = 355 (94) [M+], 354 (34), 340 (11), 316 (4), 267 (5), 251 (5), 206 (10), 
199 (7), 190 (22), 164 (100), 151 (14), 121 (10), 112 (12).  
HRMS: calcd. (C21H25NO4) 355.1784; found 355.1778. 
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SYNTHESIS OF 6-TRIFLUOROMETHYLBENZYLISOQUINOLINE 
 
F3C
Br
I
164  
1-Bromo-2-iodo-4-trifluoromethyl-benzene (164): Concentrated H2SO4 (75.0 mL) was 
added dropwise to a solution of NaIO4 (12.83 g, 60.0 mmol) and I2 (15.23 g, 60.0 mmol) 
in a 2:1 mixture AcOH/ Ac2O (75 mL) at 5-10°C. Then, 4-bromo-trifluorotoluene 162 
(11.25 g, 50.0 mmol) was added dropwise and the mixture was stirred at 25°C for 21 h. 
The mixture was poured into ice-water containing Na2SO3 and the crude products were 
extracted with CH2Cl2 (3x50 mL). The combined organic layers were dried with MgSO4 
and concentrated under vacuum. After purification by flash chromatography (SiO2, PE), 
arylhalide 164 was isolated as a yellowish oil (16.92 g, 48.22 mmol, 96%). 
1H NMR (300 MHz, CDCl3): δ = 7.44 (ddd, J = 0.6, 1.0, 8.3 Hz, 1 H), 7.74 (d, J = 8.4 
Hz, 1 H), 8.08-8.09 (m, 1 H) ppm. 
13C NMR (75 MHz, CDCl3): δ = 110.4 (C), 122.6 (q, J = 273 Hz, CF3), 126.1 (q, J = 4 
Hz, CH), 130.6 (q, J = 34 Hz, C), 133.0 (CH), 134.0 (C), 137.0 (q, J =4 Hz, CH) ppm. 
IR: υ̃ = 1591, 1459, 1377, 1317, 1257, 1173, 1132, 1102, 1074, 1074, 1012, 893, 825, 
800,705, 653, 615 cm-1. 
MS: m/z (%) = 352 (100) [M+, 81Br], 350 (34) [M+, 79Br], 333, 302, 271, 238, 223, 208, 
144, 143, 75, 74. 
 
Preparation of a solution of monomeric formaldehyde in THF: The mixture of dried 
paraformaldehyde (3.00 g) (two days in exicator with phosphor pentoxide as drying 
agent), THF (100 mL) and some drops of a solution of BF3 in diethylether was refluxed 
at 70°C for 2 h. Then, a slow distillation of the mixture was maintained and the solution 
of monomeric formaldehyde in THF was collected into a two-necked flask in -70°C. The 
concentration of the solution is ~0.8 M. 
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Preparation of a solution of iPr-MgCl•LiCl: Magnesium turning (5.36 g, 220.0 mmol) 
and anhydrous LiCl (8.48 g, 200.0 mmol) were placed in an Ar-flushed flask and THF 
(50 mL) was added. After a solution of iPrCl (18.3 mL, 200.0 mmol) in THF (50 mL) 
has been slowly added, the reaction mixture was stirred at 25°C 20 h. The deep grey 
solution of iPrMgCl•LiCl was transferred via syringes to another flask under Ar 
atmosphere. The solution is stored at -20°C. Concentration of the solution of 
iPrMgCl•LiCl is ~2.0 M. 
 
F3C
Br
OH
167  
(2-Bromo-5-trifluoromethyl-phenyl)-methanol (167): At -20°C, a solution of 
iPrMgCl•LiCl in THF (12.5 mL, 25.0 mmol, 2.0 M) was slowly added to a solution of 2-
bromo aryl iodide 164 (8.75 g, 25.0 mmol) in THF (12.5 mL). After the mixture has 
been stirred at -20°C for 2 h, a solution of monomeric formaldehyde in THF (35.0 mL, 
28.0 mmol, 0.8 M) was added. After the mixture has been stirred for additional 1 h, 
water (50 mL) was then added and the mixture was extracted with diethylether (5x30 
mL). The combined organic layers were dried with MgSO4 and concentrated under 
vacuum. After purification by flash chromatography (SiO2, PE:EE, 9:1) benzylalcohol 
167 was isolated as a white solid (4.60 g, 18.04 mmol, 72%).  
M.p.: 66-67°C. 
1H NMR (300 MHz, CDCl3): δ = 2.37 (br. s, 1 H), 4.37 (s, 2 H), 7.40 (dd, J = 1.9, 8.3 
Hz, 1 H), 7.65 (d, J = 8.3 Hz, 1 H), 7.79 (d, J = 1.3 Hz, 1 H). 
 13C NMR (75 MHz, DEPT, CDCl3): δ = 64.3 (CH2), 123.8 (q, J = 272 Hz, C), 125.1 (q, 
J = 4 Hz, CH), 125.5 (q, J = 4 Hz, CH), 125.7 (q, J = 1Hz, C), 130.1 (q, J = 33 Hz, C), 
132.9 (CH), 140.8 (C) ppm. 
IR: υ̃ = 3300, 2913, 1605, 1583, 1474, 1413, 1372, 1330, 1257, 1184, 1120, 1083, 157, 
1023, 897, 834, 829, 745, 716, 435 cm-1. 
MS: m/z (%) = 256 (35) [M+, 81Br], 254 (34) [M+, 79Br], 237 (15), 175 (100), 145 (41), 
127 (51), 113 (7), 77 (11). 
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HRMS: calcd. (C8H679BrF3O) 253.9554; found 253.9559. 
C8H6BrF3O (255.0) calcd.: C 37.68, H 2.37; found C 37.49, H 2.41. 
F3C
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2-Bromo-5-(trifluoromethyl)benzoic acid (168): At -20°C, a solution of iPrMgCl•LiCl in 
THF (5.0 mL, 25.0 mmol, 2.0 M) was slowly added to a solution of 2-bromo aryl iodide 
164 (3.50 g, 10.0 mmol) in THF (5.0 mL). After the mixture has been stirred at -20°C 
for 2 h, dried ice (1.0 g, 22.0 mmol) was added. After the mixture has been stirred for 
additional 1 h, water (50 mL) was then added and the mixture was extracted with 
diethylether (5x30 mL). The combined organic layers were dried with MgSO4 and 
concentrated under vacuum. After purification by flash chromatography (SiO2, PE:EE, 
9:1) the benzoic acid 168 was isolated as white solid (0.91 g, 3.39 mmol, 34%).  
M.p. 105-106°C. 
1H NMR (300 MHz, CDCl3): δ = 7.64 (dd, J = 3.4, 8.4 Hz, 1 H), 7.87 (d, J = 8.5 Hz, 1 
H), 8.28 (d, J = 2.1 Hz, 1 H), 10.94 (br. s, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 123.2 (q, J = 272 Hz, C), 126.8 (q, J = 1 Hz, C), 
129.5 (q, J = 4 Hz, CH2), 129.9 (q, J = 3 Hz, CH), 130.1 (q, J = 34 Hz, C), 135.7 (C), 
170.05 (C) ppm. 
IR: υ̃ = 3431, 3056, 1718, 1689, 1609, 1577, 1476, 1417, 1391, 1370, 1331, 1268, 1188, 
1127, 1084, 1033, 920, 837, 760,700 cm-1. 
MS: m/z (%) = 270 (100) [M+, 81Br], 268 (97) [M+, 79Br], 253 (97), 251 (99), 249 (10), 
225 (25), 223 (20), 144 (30), 125 (6), 74 (9) 
HRMS: calcd. (C8H479BrF3O2) 267.9347; found 267.9337. 
C8H4BrF3O2 (269.0): C 35.72, H 1.50; found C 35.87, H 1.61.  
 
F3C
Br
Br
169  
EXPERIMENT SECTION 
 79
1-Bromo-2-bromomethyl-4-trifluoromethyl-benzene (169): PBr3 (0.68 g, 2.5 mmol) was 
added to a solution of benzylalcohol 167 (1.27 g, 5.0 mmol) in CH2Cl2 (25 mL). After 
the solution has been stirred at 25°C for 24 h, a saturated aqueous Na2CO3 solution (50 
mL) was added. The mixture was extracted with CH2Cl2 (5x30 mL). The combined 
organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, PE), bromobenzyl 169 was isolated as a 
colorless oil (1.25 g, 3.93 mmol, 79%). 
1H NMR (300 MHz, CDCl3): δ = 4.61 (s, 2 H), 7.42 (dd, J = 1.0, 8.4 Hz, 1 H), 7.71 (s, 1 
H), 7.72 (d, J = 7.5 Hz, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 32.0 (CH2), 123.4 (q, J = 272 Hz, C), 126.6 (q, 
J = 4 Hz, CH), 127.9 (q, J = 4 Hz, CH), 128.8 (C), 130.5 (q, J = 33 Hz, C), 134.0 (CH), 
138.1 (C) ppm. 
IR (KBr): υ̃ = 2834, 1605, 1580, 1479, 1440, 1409, 1333, 1276, 1220, 1198, 1173, 1131, 
1081, 1032, 949, 908, 829, 908, 829, 758, 728, 588 cm-1. 
MS: m/z (%) = 320 (8) [M+, 81Br+81Br], 318 (16) [M+, 81Br+79Br], 316 (10) [M+, 
79Br+79Br], 284 (17), 239 (100), 237 (100), 158 (42), 151 (12), 113 (8), 107 (7), 89 (8), 
63 (8) 
HRMS: calcd. (C8H579Br2F3) 315.8710; found 315.8703 
 
F3C
Br
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(2-Bromo-5-trifluoromethyl-phenyl)-acetonitrile (170): A solution of NaCN (0.49 mg, 
10.0 mmol) in DMSO (2.5 mL) was heated to 90°C. The oil bath was removed and 
bromobenzyl 169 (1.59 g, 5.0 mmol) was slowly added. After the mixture had been 
allowed to reach 50°C, water (25 mL) was added. The mixture was extracted with 
CH2Cl2 (5×40 mL). The combined organic layers were dried with MgSO4 and the 
solvent was evaporated under vacuum. After purification by flash chromatography 
(SiO2, PE/EE, 95:5), o-bromo-benzylnitrile 170 (0.81 mg, 3.1 mmol, 62%) was isolated 
as a white solid.  
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M.p.: 61-62°C. 
1H NMR (300 MHz, CDCl3): δ = 3.90 (s, 2 H), 7.50 (dd, J = 1.5, 8.9 Hz, 1 H), 7.76 (d, J 
= 8.7 Hz, 1 H), 7.78 (s, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 24.9 (CH2), 116.0 (C), 123.3 (q, J = 273 Hz, C), 
126.5 (q, J = 4 Hz, CH), 126.7 (q, J = 4 Hz, CH), 127.6 (C), 130.8 (q, J = 34 Hz, C), 
131.2 (C), 133.8 (CH) ppm. 
IR: υ̃ = 3080, 2914, 2252, 1607, 1476, 1425, 1403, 1331, 1322, 1286, 1263, 1187, 1167, 
1129, 1085, 1032, 937, 877, 739, 747, 715, 421 cm-1. 
MS: m/z (%) = 265 (75) [M+, 81Br], 263 (78) [M+, 79Br], 246 (9), 244 (11), 184 (100), 
183 (21), 157 (13), 144 (4), 134 (11), 114 (6), 89 (3), 75 (4). 
HRMS: calcd. (C9H579BrF3N) 262.9557; found 262.9533. 
C9H5BrF3N (264.0): calcd. C 40.94, H 1.91, N 5.30; found C 40.71, H 1.96, N 5.20.  
 
F3C CN
OCH3
OCH3
171  
[2-(3,4-Dimethoxy-phenylethynyl)-5-trifluoromethyl - phenyl] - acetonitrile (171): 
Pd(PPh3)2Cl2 (85 mg, 0.12 mmol, 4 mol-%), CuI (46 mg, 0.24 mmol, 8 mol-%), PPh3 
(63 mg, 0.24 mmol, 8 mol-%) and a 3:1 mixture of iPr2NH//DMF (12.0 mL) were placed 
in a round-bottomed flask. After the addition of aryl bromide 170 (789 mg, 3.00 mmol), 
the mixture was stirred at 25°C for 1 h, and alkyne 121 (486 mg, 3.00 mmol) was then 
added. After the mixture had been stirred at 80°C for additional 16 h, saturated NH4Cl 
solution was added. The mixture was extracted with MTBE (3×50 mL). The combined 
organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, PE/EtOAc, 9:1), alkyn 171 (994 mg, 2.88 
mmol, 96%) was isolated as a white crystalline solid.  
M.p.: 79-80°C. 
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1H NMR (300 MHz, CDCl3): δ = 3.92 (s, 6 H), 4.01 (s, 2 H), 6.87 (d, J = 8.3 Hz, 1 H), 
7.06 (d, J = 1.9 Hz, 1 H), 7.20 (dd, J = 1.9, 8.3 Hz, 1 H), 7.60 (d, J = 8.1 Hz, 1 H), 7.67 
(d, J = 8.1 Hz, 1 H), 7.74 (s, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 22.9 (CH2), 56.0 (CH3), 83.6 (C), 98.7 (C), 
111.1 (CH), 113.8 (C), 114.2 (CH), 116.6 (C), 123.5 (q, J = 272 Hz, C), 125.1 (q, J = 4 
Hz, CH), 125.4 (CH), 127.0 (C), 130.4 (q, J = 33 Hz, C), 132.3 (C), 132.5 (CH), 149.9 
(C), 150.4 (C) ppm. 
IR: υ̃ = 3079, 2972, 2942, 2915, 2842, 2249, 2208, 1600, 1578, 1518, 1499, 1463, 1442, 
1426, 1320, 1273, 1251, 1229, 1165, 1137, 1105, 1076, 1020, 871, 834, 817 cm-1. 
MS: m/z (%) = 345 (100) [M+], 330 (6), 302 (8), 275 (13), 190 (6) 151 (5). 
HRMS: calcd. (C19H14F3NO2) 345.0977; found 345.1010. 
C19H14F3NO2 (345.3): calcd. C 66.09, H 4.09, N 4.06; found C 65.91, H 4.16, N 4.03. 
 
F3C
OCH3
OCH3
NH2
172  
2-[2-(3,4-Dimethoxy-phenylethynyl)-5-trifluoromethyl-phenyl]-ethylamine (172): A 
solution of AlCl3 (339 mg, 3.0 mmol) in diethylether (4.5 mL) was rapidly added to a 
solution of LiAlH4 (114 mg, 3.0 mmol) in diethylether (3.0 mL) and the mixture was 
stirred at 25°C for 30 minutes. A solution of nitrile 171 (1.04 mg, 3.0 mmol) in 
diethylether (6.0 mL) was then slowly added to the mixture. After the mixture has been 
stirred at 25°C for additional 2 h, water was added dropwise to decompose the excess of 
hydride and a solution of KOH (5.0 mL, 5 M) was then added to make a basic condition. 
The colloidal mixture was extracted with diethylether (10x30 mL). The combined 
organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, MTBE/MeOH/NEt3, 9:1:0.01), 
aminoalkyne 172 (980 mg, 2.8 mmol, 93%) was isolated as a yellowish solid.  
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1H NMR (300 MHz, CDCl3): δ = 2.24 (br. s, 2 H), 3.08-3.11 (m, 4 H), 3.90 (s, 3 H), 
3.91 (s, 3 H), 6.84 (d, J = 8.3 Hz, 1 H), 7.15 (dd , J = 1.9, 8.3 Hz, 1H), 7.45 (d, J = 8.1 
Hz, 1 H), 7.49 (s, 1 H), 7.60 (d, J = 7.9 Hz, 1 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 38.3 (CH2), 42.2 (CH2), 55.9 (CH3), 56.0 (CH3), 
85.3 (C), 95.8 (C), 111.1 (CH), 114.1 (CH), 114.7 (C), 123.1 (q, J = 4 Hz, CH), 123.9 
(q, J = 272 Hz, C), 125.1 (CH), 126.0 (q, J = 4 Hz, CH), 127.1 (C), 129.7 (q, J = 33 Hz, 
C), 132.5 (CH), 141.8 (C), 148.8 (C), 150.01 (C) ppm. 
IR (KBr): υ̃ = 3386, 2999, 2946, 2838, 2206, 1615, 1598, 1577, 1518, 1471, 1456, 1441, 
1412, 1327, 1256, 1229, 1173, 1125, 1020, 860, 844, 833, 815, 807 cm-1. 
MS: m/z (%) = 349 (100) [M+], 334 (16), 330 (21), 318 (25), 273 (8), 233 (16), 212 (27), 
198 (22) 166 (20), 161 (16), 151 (54), 113 (12), 86 (17). 
HRMS: calcd. (C19H18F3NO2) 349.1290; found 349.1270. 
C19H18F3NO2 (349.3) calcd.: C 65.32, H 5.19, N 4.01; found C 65.31, H 5.46, N 4.28. 
 
NH
F3C
OCH3
OCH3
173  
1-(3,4-Dimethoxy-benzyl)-6-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline (173): A 
mixture of amino alkyne 172 (175 mg, 0.5 mmol) and Ind2TiMe2 (9 mg, 0.025 mmol, 5 
mol-%) in toluene (0.25 mL) in a Schlenk tube was stirred at 105°C for 16 h. After the 
obtained brown liquid had been allowed to reach room temperature, a solution of 
NaCNBH3 (63 mg, 1.0 mmol) and ZnCl2 (68 mg, 0.5 mmol) in MeOH (5.0 mL) was 
added. The reaction mixture was stirred at 25°C for 24 h. Then, saturated aqueous 
NH4Cl (25 mL) was added and the mixture was extracted with MTBE (5×25 mL). The 
combined organic layers were dried with MgSO4 and the solvent was evaporated under 
vacuum. After purification by flash chromatography (SiO2, MTBE/MeOH/NEt3, 
20:1:0.01), tetrahydrobenzylisochinoline 173 was isolated as a yellowish solid (169 mg, 
0.48 mmol, 96%). 
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M.p.: 92-94°C 
1H NMR (300 MHz, CDCl3): δ = 2.81-2.96 (m, 4 H), 3.19-3.26 (m, 2 H), 3.84 (s, 3 H), 
3.87 (s, 3 H), 4.21 (dd, J = 3.2, 9.5 Hz, 1 H), 6.71 (d, J = 1.7 Hz, 1 H), 6.79 (dd, J = 1.7, 
8.1 Hz, 1 H), 6.84 (d, J = 8.0 Hz, 1 H), 7.33-7.43 (m, 3 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 29.9 (CH2), 40.5 (CH2), 41.8 (CH2), 55.6 (CH3), 
55.8 (CH3), 57.1 (CH), 111.2 (CH), 112.1 (CH), 121.3 (CH), 122.2 (q, J = 4 Hz, CH), 
124.2 (q, J = 272 Hz, C), 126.1 (q, J = 4 Hz, CH), 126.6 (CH), 128.3 (C), 130.7 (C), 
136.2 (C), 142.5 (C), 147.7 (C), 148.9 (C) ppm. 
IR: υ̃ = 2936, 2835, 1621, 1590, 1516, 1466, 1425, 1338, 1323, 1266, 1237, 1160, 1126, 
1077, 1030, 828, 813, 764, 646 cm-1. 
MS: m/z (%) = 351 (1) [M+], 334 (4), 332 (11), 214 (6), 201 (94), 200 (100), 198 (22), 
185 (22), 173 (7), 151 (35), 131 (11), 113 (7), 107 (7).  
HRMS: calcd. (C19H20F3NO2) 351.1446; found 351.1401. 
 
NCH3
F3C
OCH3
OCH3
174  
1-(3,4-Dimethoxy-benzyl)-2-methyl-6-trifluoromethyl - 1,2,3,4 - tetrahydro-isoquinoline 
(174): Aqueous CH2O (0.5 mL, c = 37%) was added to a solution of 173 (88 mg, 0.25 
mmol) in MeOH (1.5 mL). After this mixture had been stirred at 25°C for 3 h, NaBH4 
(95 mg, 2.5 mmol) was slowly added. Subsequently, the reaction mixture was stirred at 
25°C for an additional 16 h. Then, saturated aqueous NH4Cl (15 mL) was added and the 
mixture was extracted with CH2Cl2 (3×30 mL). The combined organic layers were dried 
with MgSO4 and the solvent was evaporated under vacuum. After purification by flash 
chromatography (SiO2, MTBE/MeOH/NEt3, 95:5:1), benzylisoquinoline 174 (62 mg, 
0.17 mmol, 68%) was isolated as a yellowish oil. 
1H NMR (300 MHz, CDCl3): δ = 2.54 (s, 3 H), 2.63-2.94 (m, 4 H), 3.08-3.22 (m, 2 H), 
3.72 (s, 2 H), 3.72 (s, 3 H), 3.82 (t, J = 6.0 Hz, 1 H), 3.85 (s, 3 H), 6.45 (d, J = 1.8 Hz, 1 
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H), 6.63 (dd, J = 2.0, 8.7  Hz, 1 H), 6.76 (d, J = 8.3 Hz, 1 H), 6.82 (d, J = 8.1 Hz, 1 H), 
7.26 (d, J = 7.9 Hz, 1 H), 7.32 (s, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 26.3 (CH2), 40.4 (CH2), 42.8 (CH3), 46.9 (CH2), 
55.6 (CH3), 55.8 (CH3), 65.0 (CH), 110.9 (CH), 112.8 (CH), 121.7 (CH), 121.8 (q, J = 2  
Hz, CH), 124.2 (q, J = 272 Hz, C), 125.5 (q, J = 4 Hz, CH), 128.2 (q, J = 32 Hz, C), 
128.4 (CH), 131.5 (C), 135.4 (C), 141.7 (C), 147.4 (C), 148.4 (C) ppm. 
IR: υ̃ = 2937, 2836, 2787, 1661, 1590,1516, 1465, 1428, 1324, 1265, 1239, 1159, 1077, 
1030, 976, 894, 803, 764, 738, 645 cm-1. 
MS: m/z (%) =  363 (3) [M+-H2], 348 (4),  346 (7), 215 (75), 214 (100), 212 (24), 199 
(15), 195 (8), 186 (7), 151 (12), 113 (6). 
HRMS: calcd. (C20H22F3NO2-H2) 363.1446; found 363.1481. 
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SYNTHESIS OF 6,7-DIFLUOROBENZYLISOQUINOLINE 
 
F
Br
OH
F
176  
(2-Bromo-4,5-difluoro-phenyl)-methanol (176): To a suspension of LiAlH4 (835 mg, 
22.0 mmol) in diethylether (30 mL) in a two-necked flask with reflux condenser was 
slowly added a solution of benzoic acid 175 (4.74 g, 20.0 mmol) in diethylether (30 mL) 
at the rate such as to produce gentle reflux. After the mixture had been stirred at room 
temperature for 2 h, water was added dropwise to decompose the excess of hydride and 
then a solution of H2SO4 (25 mL, 2 M) was added to make acid condition. The mixture 
was extracted with diethylether (5x50 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum. After purification by flash 
chromatography (SiO2, ethyl acetate/PE 1:9), benzylalcohol 176 was isolated as a white 
solid (2.61 g, 11.7 mmol, 59%). 
M.p.: 70-71°C. 
1H NMR (300 MHz, CDCl3): δ = 2.08 (t, J = 5.8 Hz, 1 H), 4.68 (d, J = 5.3 Hz, 1 H), 
7.36 (d, J = 7.5 Hz, 1 H), 7.39 (d, J = 7.4 Hz, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 63.9 (CH2), 114.9 (dd, J = 4, 8 Hz, C), 117.0 (d, 
J = 19 Hz, CH), 121.6 (d, J = 20 Hz, CH), 136.8 (dd, J = 4, 5 Hz, C), 149.3 (dd, J = 13, 
251 Hz, C), 149.8 (dd, J = 12, 249 Hz, C) ppm. 
IR (KBr): υ̃ = 3303, 3061, 2917, 1614, 1600, 1494, 1471, 1443, 1399, 1362, 1293, 1219, 
1185, 1138, 1066, 981, 881, 809, 629, 527 cm-1. 
MS: m/z (%) = 224 (72) [M+, 81Br], 222 (34) [M+, 79Br], 207 (11), 203 (11), 193 (11), 
162 (10), 143 (100) 141 (22), 125 (14), 115 (68), 114 (71), 113 (37), 112 (20), 95 (27), 
74 (6), 63 (18). 
HRMS: calcd. (C7H579BrF2O ) 221,9492; found 221.9491. 
C7H5BrF2O (223.0): calcd. C 37.70, H 2.26; found C 37.75, H 2.39. 
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F
Br
Br
F
177  
1-Bromo-2-bromomethyl-4,5-difluoro-benzene (177): PBr3 (1.49 g, 5.5 mmol) was 
added dropwise to a solution of benzylalcohol 176 (2.45 g, 11.0 mmol) in CH2Cl2 (55 
mL). After the mixture had been stirred at 25°C for 24 h, a saturated aqueous Na2CO3 
solution (50 mL) was added. The mixture was extracted with CH2Cl2 (5x30 mL). The 
combined organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, PE), bromobenzyl 177 was isolated as oil 
(2.96 g, 10.3 mmol, 94%). 
1H NMR (300 MHz, CDCl3): δ = 4.5 (s, 2 H), 7.3 (dd, J = 7.9, 10.4 Hz, 1 H), 7.4 (dd, J 
= 7.4, 9.6 Hz, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 31.70 (CH2), 117.99 (dd, J = 4, 8 Hz, CH), 
119.53 (d, J = 18 Hz, CH), 122.15 (d, J = 20  Hz, CH), 133.90 (dd, J = 4, 5 Hz, C), 
149.55 (dd, J = 13, 250 Hz, C), 150.01 (dd, J = 14, 255 Hz, C)  ppm. 
IR (KBr): υ̃ = 3051, 2977, 2590, 1602, 1499, 1441, 1395, 1306, 1289, 1218, 1193, 1152, 
1115, 994, 883, 815, 737, 703, 670, 629, 575, 553 cm-1. 
MS: m/z (%) = 288 (7) [M+, 81Br+81Br], 286 (11) [M+, 81Br+79Br], 284 (6) [M+, 
79Br+79Br], 207 (97), 205 (100), 125 (33), 125 (19), 113 (8), 75 (4). 
HRMS: calcd. (C7H479Br2F2) 283.8648; found 283.8633. 
C7H4Br2F2 (285.9): calcd. C 29.41, H 1.41; found C 29.31, H 1.46.  
 
F
Br
CN
F
178  
(2-Bromo-4,5-difluoro-phenyl)-acetonitrile (178): A solution of NaCN (980 mg, 20.0 
mmol) in DMSO (5.0 mL) was heated to 90°C. The oil bath was then removed and 
bromobenzyl 177 (2.86 g, 10.0 mmol) was slowly added. After the mixture had been 
allowed to reach 50°C, water (25 mL) was added. The mixture was extracted with 
CH2Cl2 (5×40 mL). The combined organic layers were dried with MgSO4 and 
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concentrated under vacuum. After purification by flash chromatography (SiO2, PE/EE, 
9:1), cyanobenzyl 178 (1.34 mg, 5.8 mmol, 58%) was isolated as a white solid. 
M.p.: 53-54°C. 
1H NMR (300 MHz, CDCl3): δ = 3.79 (s, 2 H), 7.40 (dd, J = 7.3, 10.0 Hz, 1 H), 7.56 
(dd, J = 7.3, 9.3 Hz, 1 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 24.3 (CH2), 116.1 (C), 117.1 (dd, J = 4, 7 Hz, 
C), 118.5 (d, J = 19 Hz, CH), 122.2 (d, J = 20 Hz, CH), 126.8 (dd, J = 4, 6 Hz, C), 149.8 
(dd, J = 12, 252 Hz, C), 149.9 (dd, J = 13, 253 Hz, C) ppm. 
IR (KBr): υ̃ = 3055, 2972, 2939, 2257, 1602, 1586, 1502, 1412, 1399, 1286, 1206, 1188, 
1149, 993, 915, 887, 859, 806, 756, 626, 578 cm-1. 
MS: m/z (%) = 233 (96) [M+, 81Br], 231 (97) [M+, 79Br], 152 (100), 125 (47), 112 (5), 75 
(9). 
HRMS: calcd. (C8H479BrF2N) 230.9495; found 230.9488. 
C8H4BrF2N (232.0): calcd. C 41,41, H 1,74, N 6.04; found C 42.14, H 1.97, N5.87.  
 
F
CN
OCH3
OCH3
F
179  
[2-(3,4-Dimethoxy-phenylethynyl)-4,5-difluoro-phenyl]-acetonitrile (179): Pd(PPh3)2Cl2 
(155 mg, 0.22 mmol, 4 mol-%), CuI (84 mg, 0.44 mmol, 8 mol-%), PPh3 (115 mg, 0.44 
mmol, 8 mol-%) and a mixture of iPr2NH (5.5 mL)/DMF (5.5 mL) were placed in a 
round-bottomed flask. After addition of aryl bromide 178 (1.28 g, 5.52 mmol), the 
mixture was stirred at 25°C for 1 h, and alkyne 121 (0.90 g, 5.55 mmol) was added. 
After this mixture had been stirred at 80°C for an additional 16 h, saturated NH4Cl 
solution was added. The mixture was extracted with MTBE (3×50 mL). The combined 
organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, PE/EE, 5:1), 179 (1.36 mg, 4.34 mmol, 
79%) was isolated as a white crystalline solid. 
M.p.: 113-114°C. 
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1H NMR (300 MHz, CDCl3): δ =  3.92 (s, 5 H), 3.92 (s, 3 H), 6.86 (d, J = 8.5 Hz, 1 H), 
7.03 (d, J = 1.9 Hz, 1 H), 7.15 (dd, J = 1.8, 8.2 Hz, 1 H), 7.33 (dd, J = 7.7, 10.6  Hz, 1 
H), 7.37 (dd, J = 7.7, 10.6 Hz, 1 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 22.3 (CH2), 55.9 (CH3), 56.0 (CH3), 82.7 (C), 
96.6 (C), 111.1 (CH), 113.9 (C), 114.1 (CH), 116.7 (C), 117.6 (d, J = 19 Hz, CH), 119.9 
(dd, J = 4, 8 Hz, C), 120.9 (d, J = 19 Hz, CH), 125.2 (CH), 128.6 (dd, J = 4,8 Hz, C), 
148.2 (dd, J = 13, 35 Hz, C), 148.8 (C), 150.34 (C), 151.6 (dd, J = 13, 38 Hz, C) ppm. 
IR (KBr): υ̃ = 3005, 2966, 2939, 2839, 2257, 2214, 1600, 1578, 1517, 1466, 1445, 1424, 
1413, 1346, 1320, 1251, 1224, 1173, 1137, 1023, 882, 869, 815, 754 cm-1. 
MS: m/z (%) = 313 (100) [M+], 298 (9), 270 (10, 243 (12), 226 (12), 212 (5), 200 (5), 
161 (11), 150 (10), 112 (6), 91 (6).  
HRMS: calcd. (C18H13F2NO2) 313.0914; found 313.0930. 
C18H13F2NO2 (313.3) calcd. C 69.01, H 4.18, N 4.47; found C 69.79, H 4.24, N 4.41. 
 
F
OCH3
OCH3
F
NH2
180  
2-[2-(3,4-Dimethoxy-phenylethynyl)-4,5-difluoro-phenyl]-ethylamine (180): A solution 
of AlCl3 (467 mg, 3.50 mmol) in diethylether (4.5 mL) was rapidly added to a solution 
of LiAlH4 (133 mg, 3.50 mmol) in diethylether (3.5 mL). After the mixture had been 
stirred at 25°C for 30 minutes, a suspension of nitrile 179 (1.10 g, 3.50 mmol) in 
diethylether (7.0 mL) was slowly added. After the mixture had been stirred at 25°C for 2 
h, water was added dropwise to decompose the excess of hydride and then a solution of 
KOH (5 mL, 5 M) was added to make basic conditions. The colloidal mixture was 
extracted with diethylether (10x30 mL). The combined organic layers were dried with 
MgSO4 and concentrated under vacuum. After purification by flash chromatography 
(SiO2, MTBE/MeOH/NEt3, 9:1:0.01), aminoalkyne 180 (1.01 g, 3.18 mmol, 91%) was 
isolated as a yellowish crystalline solid. 
M.p.: 60-61°C. 
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1H NMR (300 MHz, CDCl3): δ = 2.95 (t, J = 6.4 Hz, 2 H), 3.05 (t, J = 6.1 Hz, 2 H), 3.91 
(s, 6 H), 7.00 (d, J = 1.7 Hz, 1 H), 7.05 (dd, J = 8.0,11 Hz, 1 H), 7.12 (dd, J = 1.9, 8.3 
Hz, 1 H), 7.31(7dd, J = 7.9, 11 Hz, 1 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 38.3 (CH2), 42.5 (CH2), 55.9 (CH3), 56.0 (CH3), 
111.1 (CH), 114.1 (CH), 114.9 (C), 118.0 (d, J = 18 Hz, CH), 119.7 (dd, J = 3, 7 Hz, 
CH2), 120.6 (d, J = 19 Hz, CH), 124.9 (CH), 138.96 (dd, J = 4, 5 Hz, C), 148.4 (dd, J = 
3, 247 Hz, C), 148.8 (C), 149.9 (C), 149.9 (dd, J = 3, 251 Hz, C) ppm. 
IR (KBr): υ̃ = 3441, 3040, 3012, 2935, 2834, 2794, 1609, 1591, 1517, 1461, 1417, 1329, 
1303, 1259, 1241, 1208, 1155, 1137, 1102, 1029, 861, 807, 766, 634, 622 cm-1. 
MS: m/z (%) = 317 (100) [M+], 302 (12), 288 (27), 286 (21), 273 (7), 243 (10), 241 (11), 
225 (12), 201 (36), 180 (21), 175 (12), 166 (20), 151 (75), 138 (8), 113 (6). 
HRMS: calcd. (C18H17F2NO2) 317.1227; found 317.1234. 
C18H17F2NO2 (317.3): calcd. C 68.13, H 5.40, N 4.41; found C 67.89, H 5.47, N 4.36.  
 
NH
F
OCH3
OCH3
F
181  
1-(3,4-Dimethoxy-benzyl)-6,7-difluoro-1,2,3,4-tetrahydro-isoquinoline (181): A mixture 
of aminoalkyn 180 (159 mg, 0.50 mmol), Ind2TiMe2 (9 mg, 0.025 mmol, 5 mol-%) in 
toluene (0.25 mL) in a Schlenk tube was stirred at 105°C for 16 h. After the obtained 
brown liquid had been allowed to reach room temperature, a solution of NaCNBH3 (63 
mg, 1.00 mmol) and ZnCl2 (68 mg, 0.50 mmol) in MeOH (5 mL) was added. The 
reaction mixture was stirred at 25°C for 24 h. A saturated aqueous NH4Cl solution (25 
mL) was then added and the mixture was extracted with MTBE (5×25 mL). The 
combined organic layers were dried with MgSO4 and the solvent was evaporated under 
vacuum. After purification by flash chromatography (SiO2, MTBE/MeOH/NEt3, 
20:1:0.01), tetrahydrobenzylisoquinoline 181 (154 mg, 0.48 mmol, 96%) was isolated as 
a yellowish solid. 
M.p.: 60-61°C. 
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1H NMR (300 MHz, CDCl3): δ =  1.88 (br. s, 1 H), 2.67-2.92 (m, 4 H), 3.12-3.22 (m, 2 
H), 3.86 (s, 3 H), 3.87 (s, 3 H), 4.08 (dd, J = 3.3, 9.5 Hz, 1 H), 6.74 (d, J = 1.7 Hz, 1 H), 
6.78 (dd , J = 1.7, 8.1 Hz, 1 H), 6.84 (d, J = 8.1 Hz, 1 H), 6.89 (dd, J = 8.5, 10.6 Hz, 1 
H), 7.03 (dd, J = 8.3, 11.2 Hz, 1 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 29.3 (CH2), 40.7 (CH2), 41.9 (CH2), 55.8 (CH3), 
55.9 (CH3), 56.7 (CH), 111.4 (CH), 112.3 (CH), 114.6 (dd, J = 2, 16 Hz, CH), 117.3 (dd, 
J = 3, 14 Hz, CH), 121.3 (CH), 130.7 (C), 131.9 (dd, J = 4, 5 Hz, C), 135.0 (dd, J = 3, 4 
Hz, C), 147.8 (C), 148.3 (dd, J = 13, 249 Hz, C), 148.5 (dd, J = 12, 248  Hz, C), 149.0 
(C) ppm. 
IR (KBr): υ̃ = 3007, 2944, 2840, 2211, 1698, 1678, 1517, 1465, 1442, 1407, 1342, 1283, 
1266, 1248, 1221, 1189, 1174, 1134, 1023, 882, 863, 808, 765 cm-1. 
MS: m/z (%) = 319 (2) [M+], 267 (4), 182 (17), 169 (41, 168 (100), 166 (15), 153 (16), 
151 (17),141 (7), 113 (6), 72 (11). 
HRMS: calcd. (C18H19F2NO2) 319.1384; found 319.1399. 
 
N
F
OCH3
OCH3
F CH3
182  
1 - (3,4 - Dimethoxy-benzyl) - 6,7 - difluoro - 2 - methyl- 1,2,3,4 – tetrahydrobenzyl-
isoquinoline (182):  Aqueous CH2O (0.5 mL, c = 37%) was added to a solution of 181 
(80 mg, 0.25 mmol) in MeOH (1.5 mL). After this mixture had been stirred at room 
temperature for 3 h, NaBH4 (95 mg, 2.5 mmol) was slowly added. Subsequently, the 
reaction mixture was stirred at 25°C for an additional 16 h. Then, saturated aqueous 
NH4Cl (15 mL) was added and the mixture was extracted with CH2Cl2 (3×30 mL). The 
combined organic layers were dried with MgSO4 and concentrated under vacuum. After 
purification by flash chromatography (SiO2, MTBE/MeOH/NEt3, 95:5:1), tetrahydro-
benzylisoquinoline 182 was isolated as a yellowish oil (70 mg, 0.21 mmol, 84%). 
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1H NMR (300 MHz, CDCl3): δ = 2.50 (s, 3 H), 2.54-2.54 (m, 1 H), 2.69-2.84 (m, 3 H), 
3.03-3.16 (m, 2 H), 3.69 (t, J = 6.0 Hz, 1 H), 3.79 (s, 3 H), 3.85 (s, 3 H), 6.49 (dd, J = 
8.2, 11.2 Hz, 1 H), 6.57 (d, J = 1.9 Hz, 1 H), 6.61 (dd, J = 1.7, 8.1 Hz, 1 H), 6.76 (d, J = 
8.1  Hz, 1 H), 6.84 (dd, J = 8.1, 10.9 Hz, 1 H)  ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 25.5 (CH2), 40.3 (CH2), 42.6 (CH3), 46.6 (CH2), 
55.7 (CH3), 55.8 (CH3), 64.5 (CH), 111.0 (CH), 112.8 (CH), 116.3 (d, J = 17 Hz, CH), 
116.7 (d, J = 16 Hz, CH), 121.7 (CH),130.9 (dd, J = 4, 6 Hz, C), 131.6 (C), 134.0 (dd, J 
= 4, 4 Hz, C), 147.5 (C), 147.9 (dd, J = 18, 250 Hz, C), 148.5 (dd, J = 16, 249 Hz, C), 
148.5 (C) ppm. 
IR: υ̃ =  2936, 2836, 2798, 1608, 1591, 1516, 1465, 1417, 1375, 1315, 1264, 1238, 1212, 
1157, 1140, 1085, 1030, 881, 807, 764 cm-1. 
MS: m/z (%) =  333(5) [M+], 332 (6), 316 (9), 198 (9), 183 (100), 182 (100), 180 (93), 
167 (84), 151 (40), 139 (22), 133 (10), 127 (13), 119 (16), 107 (13), 106 (14), 86 (29), 
78 (9), 65 (12). 
HRMS: calcd. (C19H21F2NO2) 333.1540; found 333.1523. 
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SYNTHESIS OF 3´,4´-DEDIMETHOXYNORLAUDANOSINE 
 
MeO
MeO
H
N CF3
O
184  
N-{2 - [2 - (3,4 - Dimethoxy - phenylethynyl) - 4,5 - dimethoxy-phenyl]-ethyl}-2,2,2- 
trifluoro -acetamide (184): Pd(PPh3)2Cl2 (112 mg, 0.16 mmol, 2 mol-%), CuI (61 mg, 
0.32 mmol, 4 mol-%), PPh3 (83 mg, 0.32 mmol, 4 mol-%), and iPr2NH (24 mL) were 
placed in a round-bottomed flask. After addition of aryl iodide 144 (3.22 g, 8.00 mmol), 
the mixture was stirred at 25°C for 30 min, and phenylacetylene 183 (0.82 g, 8.00 
mmol) was then added. After this mixture had been stirred at 25°C for an additional 16 
h, saturated NH4Cl solution was added. The mixture was extracted with CH2Cl2 (3×50 
mL). The combined organic layers were dried with MgSO4 and concentrated under 
vacuum. After purification by flash chromatography (SiO2, PE/EtOAc, 1:1), 184 (2.44 g, 
6.47 mmol, 81%) was isolated as a yellow crystalline solid. 
1H NMR (300 MHz, CDCl3): δ = 3.09 (t, J = 6.6 Hz, 2 H), 3.71-3.73 (m, 2 H), 3.88 (s, 3 
H), 3.90 (s, 3 H), 6.54 (br. s, 1 H), 6.68 (s, 1 H), 7.03 (s, 1 H), 7.34-7.38 (m, 3 H), 7.48-
7.52 (m, 2 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 33.1 (CH2), 40.7 (CH2), 55.9 (CH3), 56.0 (CH3), 
87.4 (C), 92.2 (C), 112.1 (CH), 114.7 (C), 114.8 (CH), 115.7 (q, J = 288 Hz, C), 122.9 
(C), 128.4 (CH), 131.3 (CH), 132.9 (C), 147.7 (C), 149.7 (C), 157.3 (q, J = 37 Hz, C) 
ppm. 
IR: υ̃ = 3431, 2940, 1707, 1628, 1605, 1562, 1514, 1444, 1353, 1250, 1220, 1180, 1093, 
1001, 862, 757, 691 cm-1. 
MS: m/z (%) = 377 (87) [M+], 312 (4), 281 (8), 264 (15), 252 (17), 251 (100), 236 (4), 
201 (5), 188 (5), 178 (10), 162 (14), 151 (11), 112 (9).  
HRMS: calcd. (C20H18F3NO3) 377.1239; found 377.1257. 
C20H18F3NO3 (377.4): calcd. C 63.66, H 4.81, N 3.71; found C 63.54, H 4.89, N 3.79.  
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H3CO
H3CO
NH2
185  
2-(4,5-Dimethoxy-2-(phenylethynyl)phenyl)ethanamine (185): At 0°C, aqueous KOH (5 
M, 16.0 mL, 80.0 mmol) was added to a solution of 184 (3.04 g, 8.1 mmol) in MeOH 
(80 mL). The cooling bath was removed and the mixture was stirred at 25°C for 20 h. 
Then, the MeOH was removed under vacuum and the residue was diluted with H2O (50 
mL). After extraction with CH2Cl2 (4×50 mL), the combined organic layers were dried 
with MgSO4 and concentrated under vacuum. Purification by flash chromatography 
(SiO2, EtOAc + 3% NH3) gave 185 (1.90 g, 6.8 mmol, 83%) as a very hygroscopic pale 
brown solid. 
1H NMR (300 MHz, CDCl3): δ = 2.93-3.07 (m, 4 H), 3.88 (s, 3 H), 3.89 (s, 3 H), 6.74 (s, 
1 H), 7.01 (s, 1 H), 7.30-7.36 (m, 3 H), 7.48-7.52 (m, 2 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 38.2 (CH2), 42.7 (CH2), 55.7 (CH3), 55.8 (CH3), 
88.0 (C), 91.4 (C), 112.2 (CH), 114.5 (CH), 114.6 (C), 123.3 (C), 127.8 (CH), 128.2 
(CH), 131.1 (CH), 135.0 (C), 146.9 (C), 149.2 (C) ppm. 
IR: υ̃ = 3366, 2935, 2851, 2006, 1596, 1571, 1514, 1464, 1442, 1400, 1349, 1249, 1217, 
1189, 1168, 1092, 1071, 1027, 1001, 859, 757, 692 cm-1. 
MS: m/z (%) = 281 (26) [M+], 253 (16), 252 (100), 251 (30), 237 (6), 212 (5), 207 (5), 
201 (6), 163 (6), 151 (12), 132 (4),  
HRMS: calcd. (C18H19NO2) 281.1416; found 281.1415.  
 
CH3O
CH3O
NH
186  
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1-Benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (186): A mixture of 
aminoalkyne 185 (283 mg, 1.00 mmol), Cp2TiMe2 (0.27 mL, 0.37 mmol/mL, 0.10 
mmol, 10 mol-%) in toluen (0.50 mL) in a Schlenk tube was stirred at 105°C for 16 h. 
After the obtained brown liquid had been allowed to reach room temperature, a solution 
of NaCNBH3 (126 mg, 2.00 mmol) and ZnCl2 (136 mg, 1.00 mmol) in MeOH (10 mL) 
was added. The reaction mixture was stirred at room temperature for 24 h. A saturated 
aqueous NH4Cl (25 mL) was then added and the mixture was extracted with MTBE 
(5×25 mL). The combined organic layers were dried with MgSO4 and the solvent was 
evaporated under vacuum. After purification by flash chromatography (SiO2, 
MTBE/MeOH/NEt3, 9:1:0.01), tetrahydrobenzylisoquinoline 186 (233 mg, 0.82 mmol, 
82%) was isolated as a yellowish viscous oil. 
1H NMR (300 MHz, CDCl3): δ = 2.71-2.78 (m, 2 H), 2.90-2.98 (m, 2 H), 3.18-3.24 (m, 
2 H), 3.80 (s, 3 H), 3.86 (s, 3 H), 4.17 (dd, J = 4.6, 9.4 Hz, 1 H), 6.60 (s, 1 H), 7.22-7.36 
(m, 5 H) ppm. 
13C NMR (75 MHz, DEPT, CDCl3): δ = 29.41 (CH2), 40.64 (CH2), 42.79 (CH2), 55.84 
(CH3), 55.95 (CH3), 56.85 (CH), 109.57 (CH), 111.89 (CH), 126.45 (CH), 127.26 (C), 
128.59 (CH), 129.42 (CH), 130.39 (C), 139.10 (C), 147.03 (C), 147.53 (C) ppm. 
IR: υ̃ = 3333, 2933, 2831, 1610, 1515, 1464, 1453, 1261, 1223, 1113, 1031, 859, 750, 
701 cm-1. 
MS: m/z (%) = 283 (3) [M+], 282 (17), 280 (19), 266 (10), 250 (5), 220 (7), 206 (21), 
193 (100), 192 (100), 177 (37), 176 (84), 165 (6), 161 (7), 148 (35), 147 (24), 134 (10), 
131 (19).  
HRMS: calcd. (C18H21NO2) 283.1572; found 283.1531. 
